Thiamine

Anter

• Kūpono no ...
• E kūpono paha no ...
• ʻAʻole kūpono paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO Thiamine kahi huaora, i kapa ʻia hoʻi ka huaola B1. ʻIke ʻia ka Vitamin B1 i nā meaʻai he nui me ka hū, nā hua cereal, nā pīni, nā nati, a me nā meaʻai. Hoʻohana pinepine ʻia ia me ka hui pū me nā huaʻai B ʻē aʻe, a loaʻa i nā huahana vitamin B paʻakikī. ʻO nā huaʻai B e like me ka B1 (thiamine), ka lāʻau B2 (riboflavin), ka huaʻai B3 (niacin / niacinamide), ka huaʻai B5 (pantothenic acid), ka huaʻai B6 (pyridoxine), ka huaʻai B12 (cyanocobalamin), a me ka folic acid. Eia nō naʻe, ʻaʻole i loko o kekahi mau huahana nā mea āpau āpau a komo pū kekahi i kekahi, e like me biotin, para-aminobenzoic acid (PABA), choline bitartrate, a me inositol.

Lawe ka poʻe i ka thiamine no nā kūlana e pili ana i nā pae haʻahaʻa o thiamine (thiamine deficit syndromes), me ka beriberi a me ka mumū o nā aʻalolo (neuritis) e pili ana i ka pellagra a i ʻole ka hāpai.

Hoʻohana ʻia ʻo Thiamine no ka hoʻonui ʻana i ka ʻōnaehana pale, nā pilikia digestive, ʻeha diabetic, maʻi puʻuwai, a me nā ʻano ʻē aʻe, akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana.

Hāʻawi nā mea mālama ola i nā kī thiamine no kahi maʻi hoʻomanaʻo i kapa ʻia ʻo Wernicke's encephalopathy syndrome, nā syndrome hemahema thiamine i ka poʻe maʻi nui, a me ka haʻalele ʻana i ka waiʻona.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no THIAMINE penei:

Kūpono no ...

• Thiamine nele. ʻO ka lawe ʻana i ka thiamine e ka waha e kōkua ai i ka pale ʻana a me ka mālama ʻana i ka hemahema o ka thiamine.
• ʻO kahi maʻi lolo i hoʻokumu ʻia e nā haʻahaʻa haʻahaʻa o thiamine (Wernicke-Korsakoff Syndrome). Kōkua ʻo Thiamine i ka hōʻemi ʻana i ka makaʻi a me nā ʻōuli o kahi maʻi lolo kikoʻī i kapa ʻia ʻo Wernicke-Korsakoff Syndrome (WKS). Pili kēia maʻi lolo i nā pae haʻahaʻa o thiamine. ʻIke pinepine ʻia ia i ka poʻe ʻona ʻona. ʻO ka hāʻawi ʻana i nā pana thiamine me he mea lā e kōkua i ka hoʻēmi ʻana i ka makaʻu o ka hoʻomohala ʻana iā WKS a hoʻemi i nā hōʻailona o WKS i ka wā i haʻalele ai ka ʻalekohola.

E kūpono paha no ...

• Kālepaʻa. ʻO ka lawe ʻana i thiamine kiʻekiʻe ma ke ʻano he ʻāpana o ka papaʻai e pili pū me ka hoʻēmi liʻiliʻi o ka hoʻomōhala cataract.
• Nā hōʻino kīwaha i ka poʻe me ka maʻi diabetes (diabetic nephropathy). Hōʻike ka noiʻi mua i ka lawe ʻana i ka thiamine kiʻekiʻe (300 mg i kēlā me kēia lā) e hoʻemi i ka nui o ka albumin i ka mimi i ka poʻe me ka maʻi diabetes type 2. ʻO Albumin i ka mimi kahi hōʻike o ka hōʻino ʻana o ka hakuʻala.
• Hoʻopiʻi Menstrual (dysmenorrhea). Lawe ka thiamine i mea e hōʻemi ai i ka ʻeha o ka menstrual i nā kaikamahine ʻōpio a me nā wahine ʻōpio.

ʻAʻole kūpono paha no ...

• ʻO ke kaha e hoʻomaikaʻi ai i ke kahe o ke koko i ka puʻuwai (ʻoki ʻana o CABG). Hōʻike kekahi mau noiʻi e hāʻawi ana i ka thiamine i loko o ka aa ma mua a ma hope o ka ʻoki ʻana o CABG ʻaʻole ia e alakaʻi i nā hopena maikaʻi aʻe ma mua o ka placebo.
• Hoʻopunipuni mosquito. Hōʻike kekahi mau noiʻi e lawe i nā huaʻai B, me ka thiamine, ʻaʻole kōkua i ka pale ʻana i nā mosquitos.
• Kino maʻi (sepsis). Hōʻike ka hapa nui o ka noiʻi ʻana i ka hāʻawi ʻana i ka thiamine e IV, hoʻokahi a i ʻole me ka huaora C, ʻaʻole ia e hoʻemi i ka makaʻu o ka make i nā poʻe me nā sepsis.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Ka maʻi ʻaʻai o ka cervix. Hoʻohui ʻia ka hoʻonui ʻia ʻana o ka thiamine a me nā huaʻai B ʻē aʻe me ka hoʻoliʻiliʻi o nā wahi precancerous ma ka cervix.
• Kaumaha. Hōʻike ka noiʻi mua i ka lawe ʻana i ka thiamine i kēlā me kēia lā me ka antidepressant fluoxetine e hōʻemi i nā ʻōuli o ke kaumaha ma mua o ka lawe ʻana i fluoxetine wale nō. Hōʻike ka poʻe e lawe nei i ka thiamine i nā hoʻomaikaʻi hou aʻe ma hope o 6 mau pule. Akā ma hope o 12 mau pule, like nā ʻōuli no ka poʻe e lawe ana i ka thiamine a i ʻole placebo.
• Dementia. Pili ka lawe ʻana i ka thiamine i kahi hōʻemi hoʻemi ʻia o ka dementia i ka poʻe me ka maʻi ʻona.
• Hewa puʻuwai. ʻO ka poʻe me ka puʻuwai puʻuwai e hoʻomohala i ka hemahema thiamine. Hōʻike kekahi mau noiʻi e lawe i kahi thiamine keu e hoʻomaikaʻi iki i ka hana o ka puʻuwai. Akā ʻaʻole ka thiamine e kōkua i ka poʻe e ulu koke ka naʻau ʻole a ʻaʻohe o lākou thiamine hemahema.
• ʻO Shingles (herpes zoster).Injecting thiamine ma lalo o ka ʻili me he mea lā e hoʻēmi ia i ka makaʻu, akā ʻaʻole ʻeha, i ka poʻe me nā shingles.
• Prediabetes. Hōʻike ka noiʻi mua i ka lawe ʻana i ka thiamine e ka waha e kōkua i ka hoʻemi ʻana i nā pae kō kō ma hope o ka ʻai i nā poʻe me ka prediabetes.
• ʻElemakule.
• AIDS.
• ʻAlekohola.
• Nā kūlana lolo.
• ʻEha ʻo Canker.
• Pohā ʻōpū.
• He kūlana noʻonoʻo kahi e huikau ai ke kanaka a hiki ʻole ke noʻonoʻo pono.
• Maʻi maʻi puʻuwai.
• Makemake maikaʻi ʻole.
• Nā pilikia ʻōpū.
• Kaumaha.
• Ulcerative colitis.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka thiamine no kēia mau hoʻohana.

Koi ʻia ka Thiamine e ko mākou mau kino e hoʻohana pono i nā ʻōpelu. Mālama pū kekahi ia i ka hana o ke aʻalolo kūpono.

Ke lawe ʻia e ka waha: ʻO Thiamine ʻo LIKELY SAFE ke lawe ʻia e ka waha i nā huina kūpono, ʻoiai ua loaʻa nā hopena maʻi ʻaʻai ʻole a me ka huhū o ka ʻili.

Ke hāʻawi ʻia e IV: ʻO Thiamine ʻo LIKELY SAFE ke hāʻawi kūpono ʻia e kahi kahu mālama ola. ʻO ka injection Thiamine kahi huahana i ʻae ʻia e ka FDA.

Ke hāʻawi ʻia ma ke ʻano he pū: ʻO Thiamine ʻo LIKELY SAFE ke hāʻawi kūpono ʻia e like me ke kī ʻana i ka mākala e ka mea mālama ola. ʻO nā pana Thiamine kahi huahana i ʻae ʻia e ka FDA.

ʻAʻole hiki i Thiamine ke komo pono i ke kino i kekahi poʻe i loaʻa ka pilikia o ke ake, inu nui i ka waiʻona, a i ʻole nā ​​kūlana ʻē aʻe.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻO Thiamine ʻo LIKELY SAFE no nā wahine hāpai a hānai hānai paha ke lawe ʻia i ka nui i koi ʻia o 1.4 mg i kēlā me kēia lā. ʻAʻole lawa ka ʻike e pili ana i ka palekana o ka hoʻohana ʻana i nā nui i ka wā hāpai a hānai umauma paha.

ʻAlekohola a me kahi maʻi maʻi akepau i kapa ʻia he cirrhosis: ʻO nā mea inu ʻona a me nā kānaka me ka cirrhosis he mau haʻahaʻa haʻahaʻa ko ka thiamine. Hiki ke hōʻeha ʻia ka ʻeha nerve i ka waiʻona e ka hemahema o ka thiamine. Koi paha kēia poʻe i nā mea hoʻohui thiamine.

Maʻi maʻi koʻikoʻi: ʻO ka poʻe maʻi maʻi nui e like me nā mea i loaʻa i ke kīʻaha hiki ke loaʻa nā pae haʻahaʻa o thiamine. Koi paha kēia poʻe i nā mea hoʻohui thiamine.

Hewa puʻuwai: Loaʻa i nā poʻe me ka puʻuwai puʻuwai he pae haʻahaʻa o thiamine. Koi paha kēia poʻe i nā mea hoʻohui thiamine.

Hemodialisis: Loaʻa i nā poʻe e mālama nei i nā mālama hemodialysis i nā pae haʻahaʻa o thiamine. Koi paha lākou i nā mea hoʻopili thiamine.

Nā Syndrome kahi mea paʻakikī i ke kino e komo i nā meaola (malabsorption syndromes): Loaʻa i nā poʻe me nā syndrom malabsorption he pae haʻahaʻa o thiamine. Pono paha ka thiamine i nā mea hoʻohui.

ʻAʻole ʻike ʻia inā launa kēia huahana me nā lāʻau.

Ma mua o ka lawe ʻana i kēia huahana, e kamaʻilio me kāu ʻoihana olakino inā ʻoe e lawe i nā lāʻau.

Palehua Nut

Hoʻololi nā hua Betel (areca) i nā thiamine i ke ʻano kemika no laila ʻaʻole holo pono pū kekahi. ʻO ka nau mau ʻana, ka wā lōʻihi o nā hua betel ke kōkua i ka hemahema thiamine.

Hale Lio

Loaʻa i ka Horsetail (Equisetum) kahi kemika e hiki ke luku i ka thiamine i loko o ka ʻōpū, e alakaʻi ai paha i ka hemahema thiamine. Koi ke aupuni ʻo Kanada e hōʻoia ʻia nā huahana nona ka equisetum me ka manuahi o kēia kemika. Noho ma ka ʻaoʻao palekana, a mai hoʻohana i ka horsetail inā pilikia ʻoe no ka hemahema thiamine.

Nā meaʻai i loaʻa i ka cafe

ʻO nā kemika i loko o ke kope a me ke kī i kapa ʻia he mau tannins hiki ke hana me ka thiamine, e hoʻololi ana i kahi ʻano paʻakikī e lawe i ke kino. Hiki i kēia ke alakaʻi i ka hemahema thiamine. ʻO ka mea e mahalo ai, ua loaʻa ka hemahema o ka thiamine i kahi hui o ka poʻe ma kuaʻāina ʻo Thailand i inu i ka nui o ke kī (> 1 litera i kēlā me kēia lā) a i ʻole nauʻu i nā lau kī hū i ka wā lōʻihi. Eia naʻe, ʻaʻole i loaʻa kēia hopena i nā heluna o ke Komohana, me ka hoʻohana mau ʻana i ka tī.Manaʻo nā kānaka noiʻi ʻaʻole paha he mea nui ka pilina ma waena o ke kofe a me ke tī a me ka thiamine ke ʻole ka haʻahaʻa o ka papaʻai i ka thiamine a i ʻole ka wikamina C. ʻO ka Vitamin C ke pale aku i ka pilina ma waena o thiamine a me nā tannins i loko o ke kope a me ke kī.

Mea ʻai kai

Loaʻa nā iʻa iʻa wai maka a me nā iʻa pūpū i nā kemika e luku i ka thiamine. Hiki i ka ʻai ʻana i ka iʻa maka a iʻa ʻiʻo paha ke hāʻawi i ka hemahema thiamine. Eia nō naʻe, OK ka iʻa moa a me nā iʻa iʻa. ʻAʻohe o lākou hopena i ka thiamine, ʻoiai ke kuke ʻana e luku i nā kemika e hōʻino iā thiamine.

Ua aʻo ʻia nā mahele aʻe i ka noiʻi ʻepekema:

E ka waha:

• No ka hemahema thiamine: ʻO ka mahele maʻamau o ka thiamine he 5-30 mg i kēlā me kēia lā i hoʻokahi mahele hoʻokahi a i hoʻokaʻawale ʻia i nā kaha no hoʻokahi mahina. ʻO ka mahele maʻamau no ka hemahema koʻikoʻi hiki i 300 mg i kēlā me kēia lā.
• No ka hōʻemi ʻana i ka makaʻu o ka loaʻa ʻana o ka cataract: Hoʻohana ʻia kahi papaʻai papaʻai o kēlā me kēia lā ma kahi o 10 mg o ka thiamine.
• No ka hōʻino ʻana o ka hakuʻala i ka poʻe me ka maʻi kō (diabetes diphropathy): 100 mg o ka thiamine ʻekolu mau manawa i kēlā me kēia lā no 3 mau mahina i hoʻohana ʻia.
• No ka hoʻomaʻi menstrual (dysmenorrhea): 100 mg o ka thiamine, hoʻokahi a i ʻole me 500 mg o ka iʻa iʻa, i hoʻohana ʻia i kēlā me kēia lā a hiki i 90 mau lā.

Ma ke ʻano he papaʻai meaʻai i nā mākua, 1-2 mg o thiamine i kēlā me kēia lā e hoʻohana mau ʻia. ʻO nā ʻāpana papaʻai papaʻai i manaʻo ʻia i kēlā me kēia lā (RDA) o thiamine: nā pēpē 0-6 mau mahina, 0.2 mg; nā pēpē 7-12 mahina, 0.3 mg; keiki 1-3 makahiki, 0.5 mg; nā keiki 4-8 makahiki, 0.6 mg; keikikāne 9-13 mau makahiki, 0.9 mg; nā kāne 14 mau makahiki a ʻoi aku, 1.2 mg; kaikamahine 9-13 mau makahiki, 0.9 mg; nā wahine 14-18 mau makahiki, 1 mg; nā wahine ma mua o 18 mau makahiki, 1.1 mg; nā wahine hāpai, 1.4 mg; a me nā wahine hānai umauma, 1.5 mg.

E KA INJECTION:

• No kahi maʻi lolo i hoʻokumu ʻia e nā haʻahaʻa haʻahaʻa o thiamine (Wernicke-Korsakoff Syndrome): Hāʻawi nā mea lawelawe olakino i nā pana i piha ka 5-200 mg o ka thiamine i kēlā me kēia lā no 2 mau lā.

ʻO Aneurine Hydrochloride, Antiberiberi Factor, Antiberiberi Vitamin, Antineuritic Factor, Antineuritic Vitamin, B Complex Vitamin, Chlorhydrate de Thiamine, Chlorure de Thiamine, Complexe de Vitamine B, Facteur Anti-béribéri, Facteur Antineuritique, Hydrochlorure de Thiamine, Mononitrate dei Thiamine, Thiamine Chloride, Thiamine Disulfide, Thiamine HCl, Thiamine Hydrochloride, Thiamin Mononitrate, Thiamine Mononitrate, Thiamine Nitrate, Thiamine Pyrophosphate, Thiaminium Chloride Hydrochloride, Tiamina, Vitamin B1, Vitamin B-1, Vitamina B1, Vitamine Anti-bérine , Vitamine B1.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. Smithline HA, Donnino M, Blank FSJ, et al. ʻO ka thiamine pākuʻi no ka mālama ʻana i ka maʻi puʻuwai puʻuwai koʻikoʻi: kahi hoʻāʻo ʻana i hoʻomalu ʻia. Hoʻohui ʻo BMC Altern Med. 2019; 19: 96. Nānā kiʻi ʻole.
2. Park JE, Shin TG, Jo IJ, et al. Ka hopena o ka Vitamin C a me ka Thiamine Administration ma nā lā Delirium-Free i nā mea maʻi me Septic Shock. ʻO J Clin Med. 2020; 9: 193. Nānā kiʻi ʻole.
3. Lomivorotov VV, Moroz G, Ismoilov S, et al. Kākoʻo i kahi lāʻau Thiamine kiʻekiʻe kiʻekiʻe ma nā maʻi maʻi Cardiac kiʻekiʻe e pili ana i ka Bypass Cardiopulmonary: kahi Pilot Feasibility Study (The APPLY trial). ʻO J Cardiothorac Vasc Anesth. 2020; 34: 594-600. Nānā kiʻi ʻole.
4. Chou WP, Chang YH, Lin HC, Chang YH, Chen YY, Ko CH. ʻO Thiamine no ka pale ʻana i ka ulu ʻana o ka dementia ma waena o nā mea maʻi me ka hoʻohana ʻana i ka wai ʻona: kahi noiʻi cohort lehulehu e pili ana i ka lehulehu. ʻO Nutr Clin. 2019; 38: 1269-1273. Nānā kiʻi ʻole.
5. Wald EL, Sanchez-Pinto LN, Smith CM, et al. ʻO Hydrocortisone-Ascorbic Acid-Thiamine Hoʻohana ʻia me ka Mortality ʻoi loa ma Pediatric Septic Shock. ʻO Am J Respir Crit Care Med. 2020; 201: 863-867. Nānā kiʻi ʻole.
6. Fujii T, Luethi N, Young PJ, et al; Nā kānaka noiʻi hoʻokolokolo ʻo VITAMINS. Ka hopena o ka wikamina C, hydrocortisone, a me thiamine vs hydrocortisone wale nō i ka manawa ola a me ka ʻole o ke kākoʻo vasopressor i waena o nā mea maʻi me ka weliweli septic: ʻO ka VITAMINS hoʻokolohua hoʻokolohua kaulike. JAMA 2020 Jan 17. doi: 10.1001 / jama.2019.22176. Nānā kiʻi ʻole.
7. ʻO Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, Vitamin C, a me Thiamine no ka hoʻomaʻamaʻa ʻana i nā Sepsis Maʻi a me nā Shock Septic: He Retrospective Ma mua o Ma hope o ka hoʻopaʻa ʻana. Umauma 2017 Iune; 151: 1229-1238. Nānā kiʻi ʻole.
8. Ghaleiha A, Davari H, Jahangard L, et al. Ua hoʻomaikaʻi ʻo Adjuvant thiamine i nā mea maʻi maʻamau me nā maʻi depressive nui: nā hopena mai kahi hoʻokolohua hoʻokolohua kaulua ʻia, pālua makapō, a me kahi hoʻokolokolo. ʻO Eur Arch Psychiatry Clin Neurosci. 2016 Dec; 266: 695-702. Nānā kiʻi ʻole.
9. ʻO Jain A, Mehta R, Al-Ani M, Hill JA, Winchester DE. Ke hoʻoholo nei i ke kuleana o ka hemahema o ka thiamine i ka systolic puʻuwai puʻuwai: kahi meta-analysis a me ka loiloi ʻōnaehana. J Kāleka Kāleka. 2015 Dec; 21: 1000-7. Nānā kiʻi ʻole.
10. Donnino MW, Andersen LW, Chase M, et al. Hoʻokolohua makapō makapō, hoʻokolohua hoʻokolohua placebo o thiamine ma ke ʻano he resuscitator metabolic i septic shock: kahi papa pailaka. ʻO Med Med Crit. 2016 Pepeluali; 44: 360-7. Nānā kiʻi ʻole.
11. Andersen LW, Holmberg MJ, Berg KM, et al. ʻO Thiamine ma ke ʻano he hoʻoponopono hoʻopili i ke kīʻaha puʻuwai: kahi randomized, blind-blind, placebo-control, phase II trial. Mālama Crit. 2016 Mar 14; 20: 92. Nānā kiʻi ʻole.
12. Moskowitz A, Andersen LW, Cocchi MN, Karlsson M, Patel PV, Donnino MW. ʻO Thiamine ma ke ʻano he pale pale pale lākī ma septic shock. ʻO kahi loiloi ʻelua o kahi hoʻokolohua kaulike, pālua makapō, kahi placebo-kāohi ʻia. ʻO Ann Am Thorac Soc. 2017 Mei; 14: 737-71. Nānā kiʻi ʻole.
13. ʻO Bates CJ. Mokuna 8: Thiamine. I: Zempleni J, Rucker RB, McCormick DB, Suttie JW, eds. Puke lima o nā wikamina. Hoʻopuka ʻehā. Boca Raton, FL: CRC Paʻi; 2007. 253-287.
14. ʻO HM maikaʻi loa. ʻO ka moʻolelo o thiamine. ʻO Ann N Y Acad Sci. 1962; 98: 385-400. Nānā kiʻi ʻole.
15. Schoenenberger AW, Schoenenberger -Berzins R, der Maur CA, et al. ʻO ka hoʻohui Thiamine i ka hōʻino puʻuwai maʻi hōʻailona: kahi randomized, blind-blind, placebo-control, cross-over pilot study. ʻO Clin Res Cardiol. 2012 Malaki; 101: 159-64. Nānā kiʻi ʻole.
16. ʻO Arruti N, Bernedo N, Audicana MT, Villarreal O, Uriel O, Muñoz D. Systemic maʻi maʻi dermatitis i hoʻokumu ʻia e thiamine ma hope o ka iontophoresis. Kāhea iā Dermatitis. 2013 Dec; 69: 375-6. Nānā kiʻi ʻole.
17. Alaei-Shahmiri F, Soares MJ, Zhao Y, et al. ʻO ka hopena o ke kākoʻo thiamine ma ke kahe o ke koko, lipid serum a me ka protein C-reactive i kēlā me kēia kanaka me hyperglycemia: kahi hoʻokolohua keu, blind-blind cross-over. ʻO Diabetes Metab Syndr. 2015 Apr 29. pii: S1871-402100042-9. Nānā kiʻi ʻole.
18. Alaei Shahmiri F, Soares MJ, Zhao Y, et al. Hoʻonui ka hoʻoliʻiliʻi thiamine kiʻekiʻe i ka hoʻomanawanui ʻana o ka glucose i nā kānaka hyperglycemic: kahi hoʻokolokolo kaulua, makapō makapō makapō. ʻO Eur J Nutr. 2013 ʻOkakopa; 52: 1821-4. Nānā kiʻi ʻole.
19. Xu G, Lv ZW, Xu GX, Tang WZ. ʻO Thiamine, cobalamin, i hoʻopili ʻia i kahi a i ʻole hui pū ʻia no ka ʻume herpetic: kahi hoʻokolohua hoʻokolohua kaulike kaulike ʻia. ʻO Clin J Pain 2014; 30: 269-78. Nānā kiʻi ʻole.
20. ʻO Hosseinlou A, Alinejad V, Alinejad M, Aghakhani N. Nā hopena o nā capsule aila iʻa a me nā papa huaʻai B1 i ka lōʻihi a me ke koʻikoʻi o ka dismenorrhea i nā haumāna o ke kula kiʻekiʻe ma Urmia-Iran. Glob J Health Sci 2014; 6 (7 Spec No): 124-9. Nānā kiʻi ʻole.
21. Assem, E. S. K. Anaphylactic hopena i ka thiamine. Hoʻomaʻamaʻa 1973; 211: 565.
22. Stiles, M. H. Hypersensitivity i ka thiamine chloride me kahi memo e pili ana i ka pyridoxine hydrochloride. ʻO J Allergy 1941; 12: 507-509.
23. ʻO Schiff, L. Collapse ma hope o ka mālama ʻana o nā makua i ka hopena o thiamine hydrochloride. JAMA 1941; 117: 609.
24. ʻO Bech, P., Rasmussen, S., Dahl, A., Lauritsen, B., a me Lund, K. Ka unuhi ʻana i ka maʻi syndrome no ka wai ʻona a me nā lāʻau psychoactive pili. Nord Psykiatr Tidsskr 1989; 43: 291-294.
25. Stanhope, J. M. a me McCaskie, C. S. Ke ʻano loiloi a me nā koi lāʻau i ka detoxification chlormethoazole mai ka waiʻona. Aust Drug Alcohol Rev 1986; 5: 273-277.
26. Kristensen, C. P., Rasmussen, S., Dahl, A., a me et al. ʻO ka pālākiō syndrome withdrawal no ka wai ʻona a me nā lāʻau psychoactive e pili ana: nā helu piha no nā alakaʻi no ka mālama ʻana me phenobarbital. Nord Psykiatr Tidsskr 1986; 40: 139-146.
27. ʻO Schmitz, R. E. Ka pale a me ka mālama ʻana i ka maʻi ʻalopoko withdrawal Syndrome e ka hoʻohana ʻana i ka wai ʻona Ka Waihona Waihona 1977; 3: 575-589.
28. Sonck, T., Malinen, L., a me Janne, J. Carbamazepine i ka mālama ʻana i ka syndrome syndrome withdrawal i nā mea ʻona ʻona: nā ʻano hana. I: Rationality of Drug Development: Exerpta Medica International Congress Series No. 38. Amsterdam, ka Netherlands: Exerpta Medica; 1976.
29. Hart, W. T. He hoʻohālikelike o promazine a me paraldehyde ma 175 mau hihia o ka haʻalele ʻana i ka waiʻona. ʻO Am J Psychiatry 1961; 118: 323-327.
30. Nichols, M. E., Meador, K. J., Loring, D. W., a me Moore, E. E. Nā ʻike mua e pili ana i nā hopena maʻi o ka thiamine kiʻekiʻe ma nā waiʻona e pili ana i nā maʻi noʻonoʻo.

31. ʻO Esperanza-Salazar-De-Roldan, M. a me Ruiz-Castro, S. Hoʻomaʻamaʻa me ka ibuprofen a me nā huaora E. Revista de Obstetricia y Ginecologia de Venezuela 1993; 53: 35-37.

    
    

32. Fontana-Klaiber, H. a me Hogg, B. Nā hopena therapeutic o ka magnesium i ka dismenorrhea. ʻO Schweizerische Rundschau huluhulu Medizin Praxis 1990; 79: 491-494.

33. ʻO Davis, L. S. Stress, wikamina B6 a me ka magnesium i nā wahine me a me ka ʻole o ka dismenorrhea: kahi hoʻohālikelike a me ka noiʻi noiʻi [dissertation]. 1988;

34. ʻO Baker, H. a me Frank, O. Hoʻomaʻamaʻa, hoʻohana a me ka pono pono o nā allithiamines i hoʻohālikelike ʻia me nā thiamines hiki ke hoʻonā ʻia e ka wai. ʻO J Nutr Sci Vitaminol (Tokyo) 1976; 22 SUPPL: 63-68. Nānā kiʻi ʻole.
35. Melamed, E. ʻO ka hyperglycaemia reactive i nā mea maʻi me ka hahau nui. ʻO J Neurol.Sci 1976; 29 (2-4): 267-275. Nānā kiʻi ʻole.
36. Hazell, A. S., Todd, K. G., a me Butterworth, R. F. Nā ʻano hana o ka make ʻana o ke kikowaena neuronal i ka encephalopathy o Wernicke. ʻO Metab Brain Dis 1998; 13: 97-122. Nānā kiʻi ʻole.
37. Centerwall, B. S. a me Criqui, M. H. Kāohi ʻana i ka Wernicke-Korsakoff Syndrome: kahi kālailai pōmaikaʻi waiwai. N.Engl J Med 8-10-1978; 299: 285-289. Nānā kiʻi ʻole.
38. Krishel, S., SaFranek, D., a me Clark, R. F. Intravenous vitamins no ka poʻe ʻona i ka keʻena pilikia: kahi loiloi. ʻO J Emerg. Med 1998; 16: 419-424. Nānā kiʻi ʻole.
39. Boros, L. G., Brandes, J. L., Lee, W. N., Cascante, M., Puigjaner, J., Revesz, E., Bray, T. M., Schirmer, W. J., a me Melvin, W. S. Thiamine i mea hoʻonui i nā maʻi maʻi ʻaʻai: he pahi kaua ʻelua. Anticancer Res 1998; 18 (1B): 595-602. Nānā kiʻi ʻole.

40. Valerio, G., Franzese, A., Poggi, V., a me Tenore, A. Ka lōʻihi o ka mālama ʻana i ka maʻi diabetes i ʻelua mau maʻi me ka megaloblastic anemia syndrome me ka thiamine. Mālama Diabetes 1998; 21: 38-41.

    Nānā kiʻi ʻole.

41. Hahn, J. S., Berquist, W., Alcorn, D. M., Chamberlain, L., a me Bass, D. Wernicke encephalopathy a me beriberi i ka wā o ka nui o nā meaʻai makua e pili ana i ka loaʻa ʻole o ka infusion multivitamin. Nā Pediatrics 1998; 101: E10.

    Nānā kiʻi ʻole.
42. Tanaka, K., Kean, E. A., a me Johnson, B. ʻO ka maʻi luaʻi ʻo Jamaican. ʻO ka hoʻokolokolo biochemical o nā hihia ʻelua. N.Engl J Med 8-26-1976; 295: 461-467. Nānā kiʻi ʻole.
43. ʻO McEntee, W. J. Wernicke's encephalopathy: kahi kuhiakau excitotoxicity. ʻO Metab Brain Dis 1997; 12: 183-192. Nānā kiʻi ʻole.
44. Blass, J. P. a me Gibson, G. E. Abnormality o kahi thiamine-e koi ana i ka enzyme i nā mea maʻi me Wernicke-Korsakoff syndrome. N.Engl J Med 12-22-1977; 297: 1367-1370. Nānā kiʻi ʻole.
45. Rado, J. P. Ka hopena o nā mineralocorticoids ma ka hyperkalemia glucose i hoʻokomo ʻia i ka glucose i nā mea maʻi nondiabetic me hypoaldosteronism wae. ʻO Res Commun Chem Pathol. Farmacol 1977; 18: 365-368. Nānā kiʻi ʻole.
46. Sperl, W. [ʻImiʻike a me ka hoʻōla o mitochondriopathies]. Wien Klin Wochenschr. 2-14-1997; 109: 93-99. Nānā kiʻi ʻole.
47. Flacke, J. W., Flacke, W. E., a me Williams, G. D. Huʻi pulmonary edema ma hope o ka hoʻohuli ʻana o naloxone o ka anesthesia morphine kiʻekiʻe. Anesthesiology 1977; 47: 376-378. Nānā kiʻi ʻole.
48. Gokhale, L. B. Hoʻōla curative o ka maʻi nui (spasmodic) dysmenorrhoea. ʻO India J Med Res. 1996; 103: 227-231. Nānā kiʻi ʻole.
49. Robinson, B. H., MacKay, N., Chun, K., a me Ling, M. Nā maʻi o pyruvate carboxylase a me ka pyruvate dehydrogenase complex. ʻO J Inherit. Metab Dis 1996; 19: 452-462. Nānā kiʻi ʻole.

50. Walker, U. A. a me Byrne, E. ʻO ka hoʻomaʻamaʻa o ka encephalomyopathy kaula hanu: he loiloi koʻikoʻi o ka wā i hala a me ka ʻike o kēia manawa. ʻO Acta Neurol. Scand 1995; 92: 273-280.

    Nānā kiʻi ʻole.

51. Pietrzak, I. [Hoʻohaunaele ka wikamina i ka lawa ʻole o ka hōʻino paʻa. I. Nā wikamina hiki ke hoʻoheheʻe wai]. Przegl.Lek. 1995; 52: 522-525.

    Nānā kiʻi ʻole.
52. ʻO Turkington, R. W. Encephalopathy i hoʻokomo ʻia e nā lāʻau hypoglycemic oral. Arch Intern Med 1977; 137: 1082-1083. Nānā kiʻi ʻole.
53. Hojer, J. Severe metabolic acidosis i loko o ka waiʻona: ʻokoʻa ʻike a me ka hoʻokele. Hum Exp Toxicol 1996; 15: 482-488. Nānā kiʻi ʻole.
54. ʻO Macias-Matos, C., Rodriguez-Ojea, A., Chi, N., Jimenez, S., Zulueta, D., a me Bates, C. J. ʻO nā hōʻike bichemical o ka pau ʻana o ka thiamine i ka wā o ke ahulau neuropathy Cuban, 1992-1993. ʻO Am J Clin Nutr 1996; 64: 347-353. Nānā kiʻi ʻole.
55. Begley, T. P. Ke biosynthesis a me ka hoʻohaʻahaʻa o thiamin (wikamina B1). Nat.Prod.Rep. 1996; 13: 177-185. Nānā kiʻi ʻole.

56. ʻO Avsar, A. F., Ozmen, S., a me Soylemez, F. Vitamin B1 a me B6 pani i ka hāpai ʻana no ka ʻūhā wāwae. ʻO Am.J.Obstet.Gynecol. 1996; 175: 233-234.

    Nānā kiʻi ʻole.
57. Andersson, J. E. [Wernicke’s encephalopathy]. Ugeskr Laeger 2-12-1996; 158: 898-901. Nānā kiʻi ʻole.
58. ʻO Tallaksen, C. M., Sande, A., Bohmer, T., Bell, H., a me Karlsen, J. Kinetics o thiamin a me nā thiamin phosphate esters i loko o ke koko kanaka, ka plasma a me ka mimi ma hope o 50 mg i loko o ka waha a i ʻole waha waha paha. Eur.J.Clin.Farmacol. 1993; 44: 73-78. Nānā kiʻi ʻole.
59. Fulop, M. Alika ketoacidosis. Endocrinol Metab Clin ʻAkau ʻAkau 1993; 22: 209-219. Nānā kiʻi ʻole.
60. ʻO Adamolekun, B. a me Eniola, A. Thiamine-pane maʻalahi i ka cerebellar ataxia ma hope o ka maʻi febrile. Kenekulia .fr J Med 1993; 39: 40-41. Nānā kiʻi ʻole.
61. Meador, K., Loring, D., Nichols, M., Zamrini, E., Rivner, M., Posas, H., Thompson, E., a me Moore, E. Nā ʻike mua o ka thiamine kiʻekiʻe ma ka dementia o ʻAno Alzheimer. ʻO J Geriatr. ʻO Psychiatry Neurol. 1993; 6: 222-229. Nānā kiʻi ʻole.
62. Palesetina, M. L. a me Alatorre, E. Kaohi ʻana i nā ʻōuli haʻalele waiʻona huikau: kahi noiʻi hoʻohālikelike o ka haloperidol a me chlordiazepoxide. ʻO Curr Ther Res Clin Exp 1976; 20: 289-299. Nānā kiʻi ʻole.
63. Huey, L. Y., Janowsky, D. S., Mandell, A. J., Judd, L. L., a me Pendery, M. Nā haʻawina mua e pili ana i ka hoʻohana ʻana o thyrotropin i ka hoʻokuʻu ʻana i ka hōmona i nā mokuʻāina manic, kaumaha, a me ka disphoria o ka haʻalele ʻana i ka ʻalekohola. ʻO Psychopharmacol .ull 1975; 11: 24-27. Nānā kiʻi ʻole.
64. Sumner, A. D. a me Simons, R. J. Delirium i ka poʻe ʻelemākule i hōʻola ʻia. ʻO Cleve. ʻOlin J Med 1994; 61: 258-262. Nānā kiʻi ʻole.
65. ʻO Bjorkqvist, S. E., Isohanni, M., Makela, R., a me Malinen, ʻo L. Ambulant ka mālama ʻana i nā hōʻailona haʻalele ʻana i ka waiʻona me ka carbamazepine: kahi multicentre pālua makapō hoʻohālikelike me placebo. Acta Psychiatr. Manaʻo 1976; 53: 333-342. Nānā kiʻi ʻole.
66. Bertin, P. a me Treves, R. [Wikamina B i nā maʻi rumatika: loiloi koʻikoʻi]. Therapie 1995; 50: 53-57. Nānā kiʻi ʻole.
67. Goldfarb, S., Cox, M., Singer, I., a me Goldberg, M. Acute hyperkalemia i hoʻokomo ʻia e hyperglycemia: nā ʻano hormonal. Ann Intern Med 1976; 84: 426-432. Nānā kiʻi ʻole.
68. ʻO Hoffman, R. S. a me Goldfrank, L. R. ʻO ka mea hoʻomanawanui me ka ʻike i hoʻololi ʻia. Nā hoʻopaʻapaʻa i ka hoʻohana ʻana i ka 'coma cocktail'. JAMA 8-16-1995; 274: 562-569. Nānā kiʻi ʻole.
69. ʻO Viberti, ʻo G. C. Glucose-i hoʻokomo ʻia hyperkalaemia: He mea weliweli no nā diabetes? Lancet 4-1-1978; 1: 690-691. Nānā kiʻi ʻole.
70. Martin, P. R., McCool, B. A., a me Singleton, C. K. Molecular genetics o transketolase i ka pathogenesis o ka Wernicke-Korsakoff syndrome. ʻO Metab Brain Dis 1995; 10: 45-55. Nānā kiʻi ʻole.
71. ʻO Watson, A. J., Walker, J. F., Tomkin, G. H., Finn, M. M., a me Keogh, J. A. Acute Wernickes encephalopathy i hoʻopiʻi ʻia e ka hoʻouka glucose. Ir.J Med Sci 1981; 150: 301-303. Nānā kiʻi ʻole.
72. Siemkowicz, E. a me Gjedde, A. Post-ischemic coma i loko o ka ʻiole: ka hopena o nā pae glucose koko pre-ischemic ʻokoʻa ma ke ola hou ʻana o ka metabolic cerebral ma hope o ka ischemia. ʻO Acta Physiol Scand 1980; 110: 225-232. Nānā kiʻi ʻole.
73. ʻO Kearsley, J. H. a me Musso, A. F. Hypothermia a me ke koma i ka maʻi Wernicke-Korsakoff. ʻO Med J Aust. 11-1-1980; 2: 504-506. Nānā kiʻi ʻole.
74. Andree, ʻo R. A. Ka make ʻana ma hope o ka hoʻoponopono naloxone. Anesth.Analg. 1980; 59: 782-784. Nānā kiʻi ʻole.
75. ʻO Wilkins, B. H. a me Kalra, D. Hoʻohālikelike o nā kahakaha glucose glucose i ʻike ʻia o neonatal hypoglycaemia. ʻO Arch Dis Child 1982; 57: 948-950. Nānā kiʻi ʻole.
76. ʻO Byck, R., Ruskis, A., Ungerer, J., a me Jatlow, P. Naloxone e hoʻōla i ka hopena kokain i ke kanaka. Psychopharmacol .ull 1982; 18: 214-215. Nānā kiʻi ʻole.
77. ʻO Gurll, N. J., Reynolds, D. G., Vargish, T., a me Lechner, ʻo R. Naloxone me ka ʻole o ka transfusion hoʻolōʻihi i ke ola a hoʻonui i ka hana cardiovascular i ka hypovolemic shock. ʻO J Pharmacol Exp Ther 1982; 220: 621-624. Nānā kiʻi ʻole.
78. Dole, V. P., Fishman, J., Goldfrank, L., Khanna, J., a me McGivern, R. F. Arousal o nā mea maʻi comatose ʻona-ʻona me ka naloxone. ʻO Alkohol Clin Exp Exp 1982; 6: 275-279. Nānā kiʻi ʻole.
79. ʻO Pulsinelli, W. A., Waldman, S., Rawlinson, D., a me Plum, ʻo F. Moderate hyperglycemia e hoʻonui i ka hōʻino lolo ischemic: kahi noiʻi neuropathologic i kaʻiole. Neurology 1982; 32: 1239-1246. Nānā kiʻi ʻole.
80. ʻO ʻAmona, R. A., Mei, W. S., a me Nightingale, S. D. ʻO Glucose-i hoʻokomo ʻia ʻo hyperkalemia me nā pae aldolone maʻamau. Nā aʻo ʻana i ka mea maʻi me ka diabetes mellitus. Ann Intern Med 1978; 89: 349-351. Nānā kiʻi ʻole.
81. ʻO Pulsinelli, W. A., Levy, D. E., Sigsbee, B., Scherer, P., a me Plum, F. Hoʻonui i ka pōʻino ma hope o ka hahau ʻana o ka ischemic i nā mea maʻi me hyperglycemia me ka ʻole a i ʻole ka hoʻokumu ʻia o ka maʻi diabetes. 'Am J Med 1983; 74: 540-544. Nānā kiʻi ʻole.
82. ʻO Prough, D. S., Roy, R., Bumgarner, J., a me Shannon, G. Edema pulmonary edema i nā ʻōpio olakino ma hope o nā kaona conservative o naloxone intravenous. Anesthesiology 1984; 60: 485-486. Nānā kiʻi ʻole.
83. Taff, R. H. Pulemaʻi edema ma hope o ka hoʻoponopono naloxone i kahi mea maʻi me ka ʻole o ka maʻi puʻuwai. Anesthesiology 1983; 59: 576-577. Nānā kiʻi ʻole.
84. ʻO Cuss, F. M., Colaco, C. B., a me Baron, ua hopu ʻo J. H. Cardiac ma hope o ka hoʻohuli hou ʻia ʻana o nā hopena o nā opiates me ka naloxone. Br Med J (Clin Res Ed) 2-4-1984; 288: 363-364. Nānā kiʻi ʻole.
85. Whitfield, C. L., Thompson, G., Lamb, A., Spencer, V., Pfeifer, M., a me Browning-Ferrando, M.Ka hoʻopau ʻana o 1,024 mau mea ʻalekiko me ka ʻole o nā lāʻau psychoactive. JAMA 4-3-1978; 239: 1409-1410. Nānā kiʻi ʻole.
86. ʻO Nakada, ʻo T. a me Naita, ʻo R. T. ʻAlekohola a me ka ʻōnaehana waena. ʻO Med Clin North Am 1984; 68: 121-131. Nānā kiʻi ʻole.
87. ʻO Groeger, J. S., Carlon, G. C., a me Howland, W. S. Naloxone i septic shock. ʻO Crit Care Med 1983; 11: 650-654. Nānā kiʻi ʻole.
88. ʻO Cohen, M. R., Cohen, R. M., Pickar, D., Weingartner, H., a me Murphy, D. L. Naloxone infusions i nā maʻamau. Nā hana pili i ka hana, hormonal, a me nā physiological. Arch Gen Psychiatry 1983; 40: 613-619. Nānā kiʻi ʻole.
89. Cohen, M. R., Cohen, R. M., Pickar, D., Murphy, D. L., a me Bunney, W. E., Jr. Nā hopena o ke kino o ka lawelawe ʻana o naloxone i nā mākua maʻamau. Life Sci 6-7-1982; 30: 2025-2031. Nānā kiʻi ʻole.
90. Faden, A. I., Jacobs, T. P., Mougey, E., a me Holaday, J. W. Endorphins i ka ʻeha o ke kuamoʻo hoʻokolohua: ka hopena therapeutic of naloxone. Ann Neurol. 1981; 10: 326-332. Nānā kiʻi ʻole.
91. Baskin, D. S. a me Hosobuchi, Y. Naloxone hoʻohuli i nā deficit neurological ischemic i ke kanaka. Lancet 8-8-1981; 2: 272-275. Nānā kiʻi ʻole.
92. Golbert, T. M., Sanz, C. J., Rose, H. D., a me Leitschuh, T. H. Hoʻohālikelike loiloi o nā mālama ʻana i nā syndrome haʻalele i ka ʻalekohola. JAMA 7-10-1967; 201: 99-102. Nānā kiʻi ʻole.
93. Bowman, E. H. a me Thimann, J. Hoʻomaʻamaʻa ʻana i ka ʻalekohola i ke kahua subakut. (Ke aʻo ʻana o ʻekolu mau ʻākena hana). ʻO Dis Nerv Syst. 1966; 27: 342-346. Nānā kiʻi ʻole.
94. Nā mea kūʻai aku, E. M., Zilm, D. H., a me Degani, N. C. Hoʻohālikelike ka pono o propranolol a me chlordiazepoxide i ka haʻalele ʻana i ka ʻalekohola. J Stud. ʻAlika 1977; 38: 2096-2108. Nānā kiʻi ʻole.
95. Muller, D. J. He hoʻohālikelike o ʻekolu mau hoʻokokoke ʻana i nā mokuʻāina lawe wai ʻona. Hema. ʻO Med J 1969; 62: 495-496. Nānā kiʻi ʻole.
96. Azar, I. a me Turndorf, H. Severe hypertension a me nā atrial premature contractions ma hope o ka hoʻoponopono naloxone. Anesth.Analg. 1979; 58: 524-525. Nānā kiʻi ʻole.
97. Krauss, S. Post-hypoglycaemic encephalopathy. Br Med J 6-5-1971; 2: 591. Nānā kiʻi ʻole.
98. Simpson, R. K., Fitz, E., Scott, B., a me Walker, L. Delirium tremens: kahi hiki ke pale ʻia iatrogenic a me ke ʻano o ke kaiapuni. ʻO J Am Osteopath. Assoc 1968; 68: 123-130. Nānā kiʻi ʻole.
99. ʻO Brune, F. a me Busch, H. Anticonvulsive-sedative lapaʻau o delirium alkoholicum. Q.J Stud. ʻAlika 1971; 32: 334-342. Nānā kiʻi ʻole.
100. ʻO Thomson, A. D., Baker, H., a me Leevy, C. M. Nā lauana o 35S-thiamine hydrochloride absorption i loko o ka mea ʻalekiko maʻi maʻi. ʻO J Lab Clin Med 1970; 76: 34-45. Nānā kiʻi ʻole.
101. Kaim, S. C., Klett, C. J., a me Rothfeld, B. Hoʻomaʻamaʻa ʻana i ka mokuʻāina haʻalele loa i ka waiʻona: kahi hoʻohālikelike o nā lāʻau ʻehā. ʻO Am J Psychiatry 1969; 125: 1640-1646. Nānā kiʻi ʻole.
102. Rothstein, E. Kāohi ʻana i ka hopu ʻana i ka wai ʻona: nā kuleana o diphenylhydantoin a me chlordiazepoxide. ʻO Am J Psychiatry 1973; 130: 1381-1382. Nānā kiʻi ʻole.
103. Finkle, B. S., McCloskey, K. L., a me Goodman, L. S. Diazepam a me nā make i pili i ka lāʻau. He ana ma ʻAmelika Hui Pū ʻIa a me Kanada. JAMA 8-3-1979; 242: 429-434. Nānā kiʻi ʻole.
104. Tanaka, G. Y. Palapala: Ka hopena hypertensive i naloxone. JAMA 4-1-1974; 228: 25-26. Nānā kiʻi ʻole.
105. ʻO Michaelis, L. L., Hickey, P. R., Clark, T. A., a me Dixon, W. M. Ventricular irritability e pili ana me ka hoʻohana ʻana o naloxone hydrochloride. ʻO nā hōʻike hihia ʻelua a me ka loiloi o ka hale hōʻikeʻike o ka hopena o ka lāʻau i ka hauʻoli o ka naʻau. Ann Thorac. Surg 1974; 18: 608-614. Nānā kiʻi ʻole.
106. Wallis, W. E., Donaldson, I., Scott, R. S., a me Wilson, J. Hypoglycemia masquerading ma ke ʻano cerebrovascular disease (hypoglycemic hemiplegia). Ann Neurol. 1985; 18: 510-512. Nānā kiʻi ʻole.
107. Candelise, L., Landi, G., Orazio, E. N., a me Boccardi, E. Prognostic koʻikoʻi o ka hyperglycemia i ka hahau nui loa. Arch Neurol. 1985; 42: 661-663. Nānā kiʻi ʻole.
108. Seibert, D. G. Reversible decerebrate posturing lua i hypoglycemia. Am J Med 1985; 78 (6 Pt 1): 1036-1037. Nānā kiʻi ʻole.
109. ʻO Malouf, R. a me Brust, J. C. Hypoglycemia: nā kumu, nā hōʻike neurological, a me ka hopena. Ann Neurol. 1985; 17: 421-430. Nānā kiʻi ʻole.
110. Rock, P., Silverman, H., Plump, D., Kecala, Z., Smith, P., Michael, J. R., a me kauwela, W. Ka hoʻokō ʻana a me ka palekana o naloxone i septic shock. ʻO Crit Care Med 1985; 13: 28-33. Nānā kiʻi ʻole.
111. Oppenheimer, S. M., Hoffbrand, B. I., Oswald, G. A., a me Yudkin, J. S. Diabetes mellitus a me ka make mua mai ka maʻi kō. Br Med J (Clin Res Ed) 10-12-1985; 291: 1014-1015. Nānā kiʻi ʻole.
112. ʻO Duran, M. a me Wadman, S. K. Thiamine-pane i nā hewa i hānau ʻia o ka metabolism. ʻO J Inherit. Metab Dis 1985; 8 Hōʻawi 1: 70-75. Nānā kiʻi ʻole.
113. Flamm, E. S., Young, W., Collins, W. F., Piepmeier, J., Clifton, G. L., a me Fischer, B. ʻO kahi ʻāpana I ka hoʻāʻo ʻana o ka lapaʻau naloxone i ka ʻehaʻeha o ke kuamoʻo. J Neurosurg. 1985; 63: 390-397. Nānā kiʻi ʻole.
114. Reuler, J. B., Girard, D. E., a me Cooney, T. G. Nā manaʻo o kēia manawa. ʻO ka encephalopathy a Wernicke. N.Engl J Med 4-18-1985; 312: 1035-1039. Nānā kiʻi ʻole.
115. Ritson, B. a me Chick, J. Hoʻohālikelike o ʻelua benzodiazepines i ka mālama ʻana i ka haʻalele ʻana i ka ʻalekohola: nā hopena ma nā ʻōuli a me ka hoʻōla manaʻo. Pili ka wai ʻona. 1986; 18: 329-334. Nānā kiʻi ʻole.
116. ʻO Sillanpaa, M. a me Sonck, ʻo T. Finnish mau ʻike me ka carbamazepine (Tegretol) i ka mālama ʻana i nā hōʻailona haʻalele nui i nā mea ʻona. ʻO J Int Med Res 1979; 7: 168-173. Nānā kiʻi ʻole.
117. Gillman, M. A. a me Lichtigfeld, F. J. Manaʻo hoʻohaʻahaʻa minimal e koi ʻia me ka nitrous oxide-oxygen lapaʻau o ke kūlana haʻalele wai ʻona. ʻO Br J Psychiatry 1986; 148: 604-606. Nānā kiʻi ʻole.
118. ʻO Brunning, J., Mumford, J. P., a me Keaney, F. P. Lofexidine i nā mokuʻāina haʻalele waiʻona. ʻAlekohola Alkohol 1986; 21: 167-170. Nānā kiʻi ʻole.
119. ʻO Young, G. P., Rores, C., Murphy, C., a me Dailey, R. H. Intravenous phenobarbital no ka haʻalele ʻana i ka ʻalekohola a me nā haunaele. Ann Emerg. Med 1987; 16: 847-850. Nānā kiʻi ʻole.
120. ʻO Stojek, A. a me Napierala, K. Physostigmine i nā eyedrops e hoʻoliʻiliʻi i ka ʻiʻini i ka waiʻona i ka haʻalele mua ʻana e mālama ʻia me ka carbamazepine. Mater.Med Pol. 1986; 18: 249-254. Nānā kiʻi ʻole.
121. Hosein, I. N., de, Freitas R., a me Beaubrun, M. H. Intramuscular / oral lorazepam i ka haʻalele ʻana i ka waiʻona a me nā haʻalulu delirium incipient. ʻO West India Med J 1979; 28: 45-48. Nānā kiʻi ʻole.
122. Kramp, P. a me Rafaelsen, O. J. Delirium tremens: kahi hoʻohālikelike makapō-pālua o ka diazepam a me ka mālama barbital. Acta Psychiatr. Manaʻo 1978; 58: 174-190. Nānā kiʻi ʻole.
123. ʻO Fischer, K. F., Lees, J. A., a me Newman, J. H. Hypoglycemia i nā mea maʻi maʻi. Nā kumu a me nā hopena. N.Engl J Med 11-13-1986; 315: 1245-1250. Nānā kiʻi ʻole.
124. ʻO Wadstein, J., Manhem, P., Nilsson, L. H., Moberg, A. L., a me Hokfelt, B. Clonidine a me chlomethiazole i ka haʻalele ʻana i ka waiʻona. Acta Psychiatr. Pūʻali Kūʻai 1986; 327: 144-148. Nānā kiʻi ʻole.
125. Balldin, J. a me Bokstrom, K. Ka mālama ʻana i nā hōʻailona abstinence ʻalekohola me ka alpha 2-agonist clonidine. Acta Psychiatr. Pūʻali Kūʻai 1986; 327: 131-143. Nānā kiʻi ʻole.
126. Palsson, A. ʻO ka pono o nā lāʻau chlormethiazole mua i ka pale ʻana i nā haʻalulu delirium. ʻO kahi loiloi hou ʻana i ka hopena o nā ʻōnaehana lapaʻau lāʻau ʻokoʻa ma nā kauka psychiatric Helsingborg, 1975-1980. ʻO Acta Psychiatr. Pūʻali Kūʻai 1986; 329: 140-145. Nānā kiʻi ʻole.
127. Drummond, L. M. a me Chalmers, L. Kauoha aku i ka chlormethiazole e hoʻemi ana i nā aupuni i kahi keʻena pilikia. Br J Addict. 1986; 81: 247-250. Nānā kiʻi ʻole.
128. ʻO Baines, M., Bligh, J. G., a me Madden, ʻo J. S. Tissue thiamin pae o nā meaʻona lama i ka haukapila ma mua a ma hope o nā huaora waha a makua paha. ʻAlekohola ʻAla 1988; 23: 49-52. Nānā kiʻi ʻole.
129. Stojek, A., Bilikiewicz, A., a me Lerch, A. Carbamazepine a me physostigmine eyedrops i ka mālama ʻana i ka haʻalele mua ʻana i ka waiʻona a me ke kiʻekiʻe o ka wai ʻona. Psychiatr.Pol. 1987; 21: 369-375. Nānā kiʻi ʻole.
130. Koppi, S., Eberhardt, G., Haller, R., a me Konig, P. Calcium-channel-blocks agents i ka mālama ʻana i ka haʻalele ʻana i ka waiʻona - caroverine me meprobamate i kahi noiʻi makapō makapō ʻelua. Neuropsychobiology 1987; 17 (1-2): 49-52. Nānā kiʻi ʻole.
131. Baumgartner, G. R. a me Rowen, R. C. Clonidine vs. chlordiazepoxide i ka mālama ʻana i ka syndrome withdrawal alkohol. Arch Intern Med 1987; 147: 1223-1226. Nānā kiʻi ʻole.
132. Tubridy, P. Alprazolam vs. chlormethiazole i ka haʻalele ʻana i ka wai ʻona. Br J Addict. 1988; 83: 581-585. Nānā kiʻi ʻole.
133. Massman, J. E. a me Tipton, D. M. Nā hōʻailona a me nā loiloi o nā ʻōuli: kahi alakaʻi no ka mālama ʻana i ka Syndrome withdrawal ʻalekohola. Nā Haumāna Psychoactive 1988; 20: 443-444. Nānā kiʻi ʻole.
134. Hosein, I. N., de, Freitas R., a me Beaubrun, M. H. Intramuscular / oral lorazepam i ka haʻalele ʻana i ka waiʻona a me nā haʻalulu delirium incipient. ʻO Curr Med Res Opin. 1978; 5: 632-636. Nānā kiʻi ʻole.
135. Foy, A., Malaki, S., a me Drinkwater, V. Hoʻohana i kahi pae kaulike pahuhopu i ka loiloi a me ka mālama ʻana i ka haʻalele ʻana i ka waiʻona i kahi haukapila nui. ʻO Alkohol Clin Exp Exp 1988; 12: 360-364. Nānā kiʻi ʻole.
136. Adinoff, B., Bone, G. H., a me Linnoila, M. ʻawaʻawa nui o ka etanol a me ka syndrome withdrawal ethanol. Med Toxicol Adverse Drug Exp 1988; 3: 172-196. Nānā kiʻi ʻole.
137. ʻO Cilip, M., Chelluri, L., Jastremski, M., a me Baily, R. Hoʻomaʻamaʻa mau ʻana i ka sodium thiopental no ka mālama ʻana i nā syndromes haʻalele i ka lāʻau. Hoʻomaha Hou 1986; 13: 243-248. Nānā kiʻi ʻole.
138. Blass, J. P., Gleason, P., Brush, D., DiPonte, P., a me Thaler, H. Thiamine a me ka maʻi ʻo Alzheimer. Ke aʻo pailaka. Arch Neurol. 1988; 45: 833-835. Nānā kiʻi ʻole.
139. Bonnet, F., Bilaine, J., Lhoste, F., Mankikian, B., Kerdelhue, B., a me Rapin, M. Naloxone therapy o ka haʻalulu septic kanaka. ʻO Crit Care Med 1985; 13: 972-975. Nānā kiʻi ʻole.
140. ʻO Levin, E. R., Sharp, B., Drayer, J. I., a me Weber, M. A. ʻO ke kiʻekiʻe o ka hypertension i hoʻokomo ʻia e naloxone. 'Am J Med Sci 1985; 290: 70-72. Nānā kiʻi ʻole.
141. Poutanen, P. ʻIke me ka carbamazepine i ka mālama ʻana i nā ʻōuli o ka haʻalele ʻana i nā poʻe hana ʻalekiko. ʻO Br J Addict. Nā lāʻau ʻona ʻē aʻe 1979; 74: 201-204. Nānā kiʻi ʻole.
142. ʻO Horwitz, R. I., Gottlieb, L. D., a me Kraus, M. L. ʻO ka hopena o atenolol i ka mālama ʻana i ka maʻi maʻi o ka maʻi ʻalekope haʻalele. Nā hopena o kahi hoʻokolohua hoʻokolohua kaulike. Arch Intern Med 1989; 149: 1089-1093. Nānā kiʻi ʻole.
143. ʻO Lichtigfeld, F. J. a me Gillman, M. A. ʻO ka analgesic nitrous oxide no ka haʻalele ʻana i ka waiʻona ʻoi aku ka maikaʻi ma mua o ka placebo. Int J Neurosci. 1989; 49 (1-2): 71-74. Nānā kiʻi ʻole.

144. Zittoun, J. [Macrocytic anemia]. ʻO Rev Prat. 10-21-1989; 39: 2133-2137.

     Nānā kiʻi ʻole.
145. Seifert, B., Wagler, P., Dartsch, S., Schmidt, U., a me Nieder, J. [Magnesium - kahi hana hou therapeutic alternatives in primary dysmenorrhea]. Zentralbl.Gynakol. 1989; 111: 755-760. Nānā kiʻi ʻole.
146. Radouco-Thomas, S., Garcin, F., Guay, D., Marquis, PA, Chabot, F., Huot, J., Chawla, S., Forest, JC, Martin, S., Stewart, G., a. Ke aʻo makapō makapō e pili ana i ka pono a me ka palekana o tetrabamate a me chlordiazepoxide i ka mālama ʻia ʻana o ka syndrome withdrawal alkohol. Prog.Neuropsychopharmacol. ʻO Biol Psychiatry 1989; 13 (1-2): 55-75. Nānā kiʻi ʻole.
147. Lichtigfeld, F. J. a me Gillman, M. A. Ka hopena o placebo i ka mokuʻāina haʻalele waiʻona. ʻAlekohola Alkohol 1989; 24: 109-112. Nānā kiʻi ʻole.
148. ʻO Malcolm, R., Ballenger, J. C., Sturgis, E. T., a me Anton, R. Pālua makapō i ka hoʻāʻo ʻana e hoʻohālikelike ana i ka carbamazepine i ka mālama ʻana i ka oxazepam o ka haʻalele ʻana i ka wai ʻona ʻO Am J Psychiatry 1989; 146: 617-621. Nānā kiʻi ʻole.
149. Robinson, B. J., Robinson, G. M., Maling, T. J., a me Johnson, R. H. He mea pono anei ka clonidine i ka mālama ʻana i ka haʻalele ʻana i ka wai ʻona? ʻAla ʻAla ʻAla Exp Res 1989; 13: 95-98. Nānā kiʻi ʻole.
150. Daynes, G. ʻO ka hoʻokele mua o ka waiʻona me ka hoʻohana ʻana i ka oxygen a me nitrous oxide: kahi noiʻi transcultural. Int J Neurosci. 1989; 49 (1-2): 83-86. Nānā kiʻi ʻole.
151. ʻO Cushman, P., Jr. a me Sowers, ʻo J. R. Alcohol withdrawal syndrome: nā pane a me nā hormonal i ka alpha 2-adrenergic agonist lapaʻau. ʻAla ʻAla ʻAla Exp Res 1989; 13: 361-364. Nānā kiʻi ʻole.

152. ʻO Borgna-Pignatti, C., Marradi, P., Pinelli, L., Monetti, N., a me Patrini, C. Themia i pane ʻia ʻo Thiamine i ka maʻi DIDMOAD. ʻO J Pediatr 1989; 114: 405-410.

     Nānā kiʻi ʻole.
153. Saris, W. H., Schrijver, J., van Erp Baart, M. A., a me Brouns, F. Ka lawa kūpono o ka hoʻolako ʻana i ka wikamina ma lalo o nā hana i hoʻomāhuahua loa ʻia: ʻo ka Tour de France. Int J Vitam. Nutr Res Suppl 1989; 30: 205-212. Nānā kiʻi ʻole.
154. Eckart, J., Neeser, G., Wengert, P., a me Adolph, M. [Nā hopena a me nā kūpilikiʻi o ka meaʻai makua]. ʻO Infusionstherapie. 1989; 16: 204-213. Nānā kiʻi ʻole.
155. Hillbom, M., Tokola, R., Kuusela, V., Karkkainen, P., Kalli-Lemma, L., Pilke, A., a me Kaste, M. Kāohi ʻana i ka hopu ʻana i ka waiʻona me ka carbamazepine a me ka waikawa valproic. Alkohol 1989; 6: 223-226. Nānā kiʻi ʻole.
156. Lima, L. F., Leite, H. P., a me Taddei, J. A. Nā haʻahaʻa haʻahaʻa o ke koko thiamine i nā keiki i ke komo ʻana i ka keʻena mālama koʻikoʻi: nā mea weliweli a me nā ʻano prognostic. 'Am J Clin Nutr 2011; 93: 57-61. Nānā kiʻi ʻole.
157. Smit, A. J. a me Gerrits, E. G. ʻili autofluorescence ma ke ʻano he ana o ka glycation endproduct endition end advanced: kahi mea hōʻailona makaʻu i ka maʻi maʻi maʻi maʻi mau. Curr Opin.Nephrol.Hypertens. 2010; 19: 527-533. Nānā kiʻi ʻole.
158. Sarma, S. a me Gheorghiade, M. Nutritional loiloi a me ke kākoʻo o ka mea maʻi me ka maʻi puʻuwai ʻole. Curr.Opin.Crit Care 2010; 16: 413-418. Nānā kiʻi ʻole.
159. GLATT, M. M., GEORGE, H. R., a me FRISCH, E. P. Hoʻokolokolo hoʻokolokolo ʻia o chlormethiazole i ka mālama ʻana i ka lā haʻalele wai ʻona. Br Med J 8-14-1965; 2: 401-404. Nānā kiʻi ʻole.
160. Funderburk, F. R., Allen, R. P., a me Wagman, A. M. Nā hopena koena o ka mālama ʻana o ka etanol a me chlordiazepoxide no ka haʻalele ʻana i ka waiʻona. ʻO J Nerv Ment. Hōʻike 1978; 166: 195-203. Nānā kiʻi ʻole.

161. Cho, S. H. a me Whang, W. W. Acupuncture no nā maʻi temporomandibular: kahi loiloi ʻōnaehana. J Orofac. Pain 2010; 24: 152-162.

     Nānā kiʻi ʻole.
162. Liebaldt, G. P. a me Schleip, I. 6. Apallic syndrome ma hope o ka hypoglycemia lōʻihi. Monogr Gesamtgeb.Psykiatr.Psykiatry Ser. 1977; 14: 37-43. Nānā kiʻi ʻole.
163. Avenell, A. a me Handoll, H. H. Nutritional supplementation no ka haki haʻihaʻi ma hope o ka mālama ʻana i ka poʻe kahiko. ʻO Cochrane Database Syst Rev 2010;: CD001880. Nānā kiʻi ʻole.
164. ʻO Donnino, M. W., Cocchi, M. N., Smithline, H., Carney, E., Chou, P. P., a me Salciccoli, J. Coronary artery bypass graft surgery e hoʻopau i nā pae plasma thiamine. Nutr 2010; 26: 133-136. Nānā kiʻi ʻole.
165. Nolan, K. A., ʻEleʻele, R. S., Sheu, K. F., Langberg, J., a me Blass, J. P. He hoʻokolokolo o thiamine i ka maʻi o Alzheimer. Arch Neurol. 1991; 48: 81-83. Nānā kiʻi ʻole.

166. Bergmann, AK, Sahai, I., Falcone, JF, Fleming, J., Bagg, A., Borgna-Pignati, C., Casey, R., Fabris, L., Hexner, E., Mathews, L., Ribeiro, ML, Wierenga, KJ, a me Neufeld, EJ Thiamine-pane megaloblastic anemia: ʻike ʻia o heterozygotes hui pū kekahi a me ka hoʻololi hou ʻana. ʻO J Pediatr 2009; 155: 888-892.

     Nānā kiʻi ʻole.

167. ʻO Borgna-Pignatti, C., Azzalli, M., a me Pedretti, S. Thiamine-pane megaloblastic anemia maʻi pale: lōʻihi ka ukali. ʻO J Pediatr 2009; 155: 295-297.

     Nānā kiʻi ʻole.
168. ʻO Bettendorff, L. a me Wins, P. Thiamin diphosphate i loko o ke kemika biology: nā ʻano hou o ka thiamin metabolism, ʻoi aku hoʻi nā huakaʻi triphosphate e hana ana ma mua o nā cofactors. FEBS J 2009; 276: 2917-2925. Nānā kiʻi ʻole.
169. ʻO Proctor, M. L. a me Farquhar, C. M. Dysmenorrhoea. ʻO Clin Evid (Online) 2007; 2007 Nānā i ka abstract.
170. ʻO Jurgenson, C. T., Begley, T. P., a me Ealick, S. E. ʻO ke kumu a me nā biochemical kumu o ka biosyntesis thiamin. Annu. Rev Biochem 2009; 78: 569-603. Nānā kiʻi ʻole.

171. Ganesh, R., Ezhilarasi, S., Vasanthi, T., Gowrishankar, K., a me Rajajee, S. Thiamine pane megaloblastic anemia maʻi pale. ʻO India J Pediatr 2009; 76: 313-314.

     Nānā kiʻi ʻole.
172. Masumoto, K., Esumi, G., Teshiba, R., Nagata, K., Nakatsuji, T., Nishimoto, Y., Ieiri, S., Kinukawa, N., a me Taguchi, T. Pono no ka thiamine i ka peripheral meaʻai makua makua ma hope o ka ʻōpū ʻōpū i nā keiki. ʻO JPEN J Parenter. Hoʻokena Nutr 2009; 33: 417-422. Nānā kiʻi ʻole.
173. Pēlā, Diaz A., Sanchez, Gil C., Gomis, Munoz P., a me Herreros de, Tejada A. [ʻO ke kūpaʻa o ka huaora i ka meaʻai makua. ʻO Nutr Hosp. 2009; 24: 1-9. Nānā kiʻi ʻole.
174. ʻO Bautista-Hernandez, V. M., Lopez-Ascencio, R., Del Toro-Equihua, M., a me Vasquez, C. Ka hopena o ka thiamine pyrophosphate ma nā pae o ka lactate serum, ka nui o ka ʻai ʻana o ka oxygen a me ka helu o ka puʻuwai i nā mea pāʻani e hana nei i ka hana aerobic. ʻO J Int Med Res 2008; 36: 1220-1226. Nānā kiʻi ʻole.

175. Wooley, J. A. Nā hiʻohiʻona o ka thiamin a me kona pili i ka hoʻokele o ka puʻuwai puʻuwai. ʻO Nutr Clin.Pract. 2008; 23: 487-493.

     Nānā kiʻi ʻole.
176. Martin, W. R. Naloxone. Ann Intern Med 1976; 85: 765-768. Nānā kiʻi ʻole.
177. Beltramo, E., Berrone, E., Tarallo, S., a me Porta, M. Nā hopena o ka thiamine a me ka benfotiamine ma ka intracellular glucose metabolism a me ka pilina i ka pale ʻana i nā pilikia diabetic. ʻO Acta Diabetol. 2008; 45: 131-141. Nānā kiʻi ʻole.
178. Thornalley, P. J. ʻO ke kuleana o ka thiamine (wikamina B1) i nā pilikia diabetes. Curr Diabetes Rev 2005; 1: 287-298. Nānā kiʻi ʻole.
179. Nā mea kūʻai aku, E. M., Cooper, S. D., Zilm, D. H., a me Shanks, C. Lapaʻau lithium i ka wā o ka haʻalele ʻana i ka ʻalekohola. ʻO Clin Pharmacol Ther 1976; 20: 199-206. Nānā kiʻi ʻole.
180. ʻO Sica, D. A. Loop diuretic therapy, koena thiamine, a me ka puʻuwai puʻuwai. Kūpono. Hewa ʻole. 2007; 13: 244-247. Nānā kiʻi ʻole.
181. Balk, E., Chung, M., Raman, G., Tatsioni, A., Chew, P., Ip, S., DeVine, D., a me Lau, J. B mau huaora a me nā hua a me nā maʻi neurodegenerative pili i nā makahiki. . Hōʻoiaʻiʻo ʻo Evid. Loea ʻenehana. (Piha. Rep.) 2006;: 1-161. Nānā kiʻi ʻole.
182. ʻO Tasevska, N., Runswick, S. A., McTaggart, A., a me Bingham, S. A. Iwakāluakūmāhā hola thiamine urinary ma ke ʻano he biomarker no ka loiloi i ka loaʻa o ka thiamine. Eur J Clin Nutr 2008; 62: 1139-1147. Nānā kiʻi ʻole.
183. Wahed, M., Geoghegan, M., a me Powell-Tuck, J. Novel substrates. Eur J Gastroenterol.Hepatol. 2007; 19: 365-370. Nānā kiʻi ʻole.
184. Ahmed, N. a me Thornalley, P. J. Advanced glycation hopena hopena: he aha ka pili o lākou i nā maʻi diabetic? ʻO ka maʻi diabetes. Metab 2007; 9: 233-245. Nānā kiʻi ʻole.
185. Avenell, A. a me Handoll, H. H. Nutritional supplementation no ka haki haʻihaʻi ma hope o ka mālama ʻana i ka poʻe kahiko. ʻO Cochrane Database Syst Rev 2006;: CD001880. Nānā kiʻi ʻole.
186. Mezadri, T., Fernandez-Pachon, M. S., Villano, D., Garcia-Parrilla, M. C., a me Troncoso, A. M.[Ka hua acerola: hoʻohui, ʻano hana a me ka waiwai nui]. Arch Latinoam. Nutr 2006; 56: 101-109. Nānā kiʻi ʻole.
187. Allard, M. L., Jeejeebhoy, K. N., a me Sole, M. J. Ka mālama ʻana i nā koi kūpono i ka maikaʻi ʻole o ka puʻuwai. Puʻuwai Heart. Rev. 2006; 11: 75-82. Nānā kiʻi ʻole.
188. ʻO Arora, S., Lidor, A., Abularrage, C. J., Weiswasser, J. M., Nylen, E., Kellicut, D., a me Sidawy, A. N. Thiamine (wikamina B1) hoʻomaikaʻi i ka vasodilat-dependant endothelium i ke alo o hyperglycemia. Ann Vasc.Surg 2006; 20: 653-658. Nānā kiʻi ʻole.
189. Chuang, D. T., Chuang, J. L., a me Wynn, R. M. Nā haʻawina mai nā maʻi kūlohelohe o nā lālā amino acid branched-chain. J Nutr 2006; 136 (1 Hōʻawi): 243S-249S. Nānā kiʻi ʻole.
190. Lee, B. Y., Yanamandra, K., a me Bocchini, J. A., Jr. Thiamin hemahema: kahi kumu nui paha o kekahi mau tumors? (loiloi). ʻO Oncol Rep. 2005; 14: 1589-1592. Nānā kiʻi ʻole.

191. Yang, F. L., Liao, P. C., Chen, Y. Y., Wang, J. L., a me Shaw, N. S. Prevalence o ka thiamin a me ka hemahema riboflavin i waena o nā ʻelemākule ma Taiwan. Asia Pac.J Clin Nutr 2005; 14: 238-243.

     Nānā kiʻi ʻole.
192. Nakamura, J. [Hoʻomohala ʻana i nā mea lapaʻau therapeutic for diabetic neuropathies]. Nippon Rinsho 2005; 63 Hōʻuluʻulu 6: 614-621. Nānā kiʻi ʻole.
193. Watanabe, D. a me Takagi, H. [Nā lāʻau lapaʻau hiki ke hiki mai no ka maʻi diabetic retinopathy]. Nippon Rinsho 2005; 63 Hōʻuluʻulu 6: 244-249. Nānā kiʻi ʻole.
194. Yamagishi, S. a me Imaizumi, T. [Holomua ma ke ʻano lāʻau no ka microangiopathies diabetic: AGE inhibitors]. Nippon Rinsho 2005; 63 Hōʻuluʻulu 6: 136-138. Nānā kiʻi ʻole.
195. Suzuki, S. [Ke kuleana o ka hana mitochondrial i ka maʻi pathogenesis o ka diabetic microangiopathy]. Nippon Rinsho 2005; 63 Hōʻuluʻulu 6: 103-110. Nānā kiʻi ʻole.
196. Avenell, A. a me Handoll, H. H. Nutritional supplementation no ka haki haʻihaʻi ma hope o ka mālama ʻana i ka poʻe kahiko. ʻO Cochrane Database Syst Rev 2005;: CD001880. Nānā kiʻi ʻole.
197. Jackson, R. a me Teece, S. Hōʻike kumuhana kumuhana maikaʻi. ʻO ka thiamine waha a i ʻole i loko o ka ʻoihana pōpilikia. Kū. Med J 2004; 21: 501-502. Nānā kiʻi ʻole.

198. ʻO Younes-Mhenni, S., Derex, L., Berruyer, M., Nighoghossian, N., Philippeau, F., Salzmann, M., a me Trouillas, P. Paʻi nui ke aʻa nui i kahi maʻi ʻōpio me ka maʻi o Crohn. Ke kuleana o ka vitamina B6 deficit-i hoʻokomo ʻia hyperhomocysteinemia. ʻO J Neurol.Sci 6-15-2004; 221 (1-2): 113-115.

     Nānā kiʻi ʻole.

199. ʻO Ristow, M. Neurodegenerative nā maʻi e pili ana i ka maʻi diabetes. ʻO J Mol. ʻOihana 2004; 82: 510-529.

     Nānā kiʻi ʻole.
200. ʻO Avenell, A. a me Handoll, H. H. Nutritional supplementation no ka haki haki ma hope o ka mālama ʻana i ka ʻelemakule. ʻO Cochrane Database Syst Rev 2004;: CD001880. Nānā kiʻi ʻole.
201. Greenblatt, D. J., Allen, M. D., Noel, B. J., a me Shader, R. I. Hoʻonui keu pono me nā derivatives benzodiazepine. ʻO Clin Pharmacol Ther 1977; 21: 497-514. Nānā kiʻi ʻole.

202. Lorber, A., Gazit, A. Z., Khoury, A., Schwartz, Y., a me Mandel, H. Cardiac i hōʻike ʻia i loko o ka thiamine-pane megaloblastic anemia maʻi pale. Pediatr Cardiol. 2003; 24: 476-481.

     Nānā kiʻi ʻole.
203. Okudaira, K. [Late withdrawal syndrome]. Ryoikibetsu.Shokogun.Shirizu. 2003;: 429-431. Nānā kiʻi ʻole.
204. Kodentsova, V. M. [Ka pau ʻana o nā wikamina a me kā lākou mau metabolites i ka mimi ma ke ʻano he pae hoʻohālikelike o ke kūlana huaola kanaka]. ʻO Vopr.Med Khim. 1992; 38: 33-37. Nānā kiʻi ʻole.

205. ʻO Wolters, M., Hermann, S., a me Hahn, A. B kūlana kūlana a me nā concentrations o homositistine a me methylmalonic acid i nā wahine Kelemānia makua. ʻO Am J Clin Nutr 2003; 78: 765-772.

     Nānā kiʻi ʻole.
206. ROSENFELD, J. E. a me BIZZOCO, D. H. Ke aʻo hoʻomalu ʻia no ka haʻalele ʻana i ka ʻalekohola. Q.J Stud. ʻAlika 1961; Hōʻuluʻulu 1: 77-84. Nānā kiʻi ʻole.
207. CHAMBERS, J. F. a me SCHULTZ, J. D. NĀ PALAPALUA ʻ STUDKAʻI ʻekolu mau lāʻau i loko o ka mālama ʻia ʻana o ʻAmelike ʻAmelike. Q.J Stud. ʻAlekohol 1965; 26: 10-18. Nānā kiʻi ʻole.
208. ʻO SERENY, G. a me KALANT, H. Hoʻohālikelike CLINICAL EVALUATION O CHLORDIAZEPOXIDE AND PROMAZINE I KA LOA ANA I KA LĀKAHI ALCOHOL-WITHDRAWAL. Br Med J 1-9-1965; 1: 92-97. Nānā kiʻi ʻole.
209. MOROZ, R. a me RECHTER, E. MANAGEMENT OF PATIENTS ME KA HOʻOPIʻI ME KA TREMENS DELIRIUM KĀLĀ. Psychiatr.Q. 1964; 38: 619-626. Nānā kiʻi ʻole.
210. ʻO THOMAS, D. W. a me FREEDMAN, D. X. KA LAIA ANA I KA ʻAʻOLOHOLO ALOHA ʻAʻOHOʻI. Hoʻohālikelike o PROMAZINE ME PARALDEHYDE. JAMA 4-20-1964; 188: 316-318. Nānā kiʻi ʻole.
211. GRUENWALD, F., HANLON, T. E., WACHSLER, S., a me KURLAND, A. A. Ke aʻo like o promazine a me triflupromazine i ka mālama ʻana i ka waiʻona koʻikoʻi. ʻO Dis Nerv Syst. 1960; 21: 32-38. Nānā kiʻi ʻole.
212. ECKENHOFF, J. E. a me OECH, S. R. Nā hopena o nā narcotics a me nā antagonists i ka hanu a me ke kahe o ke kanaka. He loiloi. ʻO Clin Pharmacol Ther 1960; 1: 483-524. Nānā kiʻi ʻole.
213. LATIES, V. G., LASAGNA, L., GROSS, G. M., HITCHMAN, I. L., a me FLORES, J. He hoʻokolokolo hoʻokolokolo ʻia ma chlorpromazine a me promazine i ka mālama ʻana i nā haʻalulu delirium. Q.J Stud. Alkohol 1958; 19: 238-243. Nānā kiʻi ʻole.
214. VICTOR, M. a me ADAMS, R. D. Ka hopena o ka ʻalekohola i ka ʻōnaehana hopohopo. Hoʻolaha Hoʻolaha. ʻAssoc Res Nerv Ment. Hōʻike 1953; 32: 526-573. Nānā kiʻi ʻole.
215. Kōkua iā Helphingstine, C. J. a me Bistrian, B. R. Nā Pono Pono Mea Hou a me nā lāʻau lapaʻau no ka hoʻokomo ʻana i ka wikamina K i nā multivitamins makua makua. ʻO JPEN J Parenter. Hoʻokomo Nutr 2003; 27: 220-224. Nānā kiʻi ʻole.
216. Johnson, K. A., Bernard, M. A., a me Funderburg, K. ʻAiʻai wikamina i nā mākua makua. ʻO Clin Geriatr. Med 2002; 18: 773-799. Nānā kiʻi ʻole.
217. Berger, M. M. a me Mustafa, I. Kākoʻo Metabolic a me ka meaʻai i ka maikaʻi ʻole o ka puʻuwai puʻuwai. Curr.Opin.Clin.Nutr.Metab Care 2003; 6: 195-201. Nānā kiʻi ʻole.
218. Mahoney, D. J., Parise, G., a me Tarnopolsky, M. A. Nutritional a me nā hoʻolālā hoʻoikaika kino i ka mālama ʻana i ka maʻi mitochondrial. ʻO Curr Opin Clin Nutr Metab Care 2002; 5: 619-629. Nānā kiʻi ʻole.

219. Fleming, M. D. Nā genetics o nā anemias sideroblastic hoʻoilina. Semin.Hematol. 2002; 39: 270-281.

     Nānā kiʻi ʻole.

220. de, Lonlay P., Fenneteau, O., Touati, G., Mignot, C., Billette, de, V, Rabier, D., Blanche, S., Ogier de, Baulny H., a me Saudubray, JM [Hematologic nā hōʻike o nā hewa i hānau ʻia o ka metabolism]. Arch Pediatr 2002; 9: 822-835.

     Nānā kiʻi ʻole.
221. ʻO Thornalley, P. J. Glycation i ka neuropathy diabetic: ʻano, nā hopena, nā kumu, a me nā koho therapeutic. Int Rev Neurobiol. 2002; 50: 37-57. Nānā kiʻi ʻole.

222. Kuroda, Y., Naito, E., a me Touda, Y. [Ka lāʻau lapaʻau no nā maʻi mitochondrial]. Nippon Rinsho 2002; 60 Hōʻailona 4: 670-673.

     Nānā kiʻi ʻole.
223. Singleton, C. K. a me Martin, P. R. Nā hana Molecular o ka hoʻohana ʻana i ka thiamine. ʻO Curr Mol. Med 2001; 1: 197-207. Nānā kiʻi ʻole.
224. ʻO Proctor, M. L. a me Murphy, P. A. Herbal a me nā hoʻoponopono dietary no ka mea nui a me ka lua o ka dismenorrhoea. Cochrane.Database.Syst.Rev 2001;: CD002124. Nānā kiʻi ʻole.
225. Bakker, S. J. Loaʻa i ka thiamine a me ka makaʻu o ka cataract. Ophthalmology 2001; 108: 1167. Nānā kiʻi ʻole.
226. ʻO Rodriguez-Martin, J. L., Qizilbash, N., a me Lopez-Arrieta, J. M. Thiamine no ka maʻi o Alzheimer. ʻO Cochrane Database.Syst.Rev 2001;: CD001498. Nānā kiʻi ʻole.
227. ʻO Witte, K. K., Clark, A. L., a me Cleland, J. G. Nā puʻuwai puʻuwai ʻole a me nā micronutrients. ʻO J Am Coll Cardiol 6-1-2001; 37: 1765-1774. Nānā kiʻi ʻole.

228. Neufeld, E. J., Fleming, J. C., Tartaglini, E., a me Steinkamp, ​​M. P. Thiamine-pane megaloblastic anemia maʻi: kahi maʻi o ke kiʻekiʻe-affinity thiamine lawe. Nā Cells Kolo Mol. Hōʻike 2001; 27: 135-138.

     Nānā kiʻi ʻole.
229. ʻO Ambrose, M. L., Bowden, S. C., a me Whelan, G. Thiamin ka mālama ʻana a me ka hana hoʻomanaʻo hoʻomanaʻo ʻana i ka poʻe hilinaʻi i ka waiʻona: nā ʻike mua. ʻO Alkohol Clin.Exp.Res. 2001; 25: 112-116. Nānā kiʻi ʻole.
230. ʻO Bjorkqvist, S. E. Clonidine i ka haʻalele ʻana i ka ʻalekohola. ʻO Acta Psychiatr. Helu 1975; 52: 256-263. Nānā kiʻi ʻole.
231. ʻO Avenell, A. a me Handoll, H. H. Nutritional supplementation no ka haki haki ma hope o ka mālama ʻana i ka ʻelemakule. ʻO Cochrane Database Syst Rev 2000;: CD001880. Nānā kiʻi ʻole.
232. Zilm, D. H., Sellers, E. M., MacLeod, S. M., a me Degani, N. Palapala: Ka hopena Propranolol i ka haʻalulu i ka haʻalele ʻana i ka ʻalekohola. ʻO Ann Intern Med 1975; 83: 234-236. Nānā kiʻi ʻole.
233. Rindi, G. a me Laforenza, U. Thiamine lawe ʻōpū a me nā pilikia e pili ana: nā hiʻohiʻona hou. Proc Soc Exp Biol Med 2000; 224: 246-255. Nānā kiʻi ʻole.
234. Boros, L. G. Heluna kūlana thiamine a me nā helu ʻē aʻe o ka maʻi ʻaʻai ma waena o nā ʻāina komohana, ʻAsia a me ʻApelika. Anticancer Res 2000; 20 (3B): 2245-2248. Nānā kiʻi ʻole.
235. Manore, M. M. Ka hopena o ka hoʻoikaika kino ma ka thiamine, riboflavin, a me nā koi vitamin B-6. ʻO Am J Clin Nutr 2000; 72 (2 Suppl): 598S-606S. Nānā kiʻi ʻole.
236. ʻO Gregory, M. E. Nā hōʻike o ka holomua o ka ʻEpekema Waiū. ʻO nā wikamina hiki ke hoʻonā ʻia i ka wai i ka waiū a me nā huahana waiū ʻO J Dairy Res 1975; 42: 197-216. Nānā kiʻi ʻole.
237. Cascante, M., Centelles, J. J., Veech, R. L., Lee, W. N., a me Boros, L. G. Role o thiamin (wikamina B-1) a me transketolase i ka ulu ʻana o ka cell tumor. Nutr.Cancer 2000; 36: 150-154. Nānā kiʻi ʻole.
238. ʻO Rodriguez-Martin, J. L., Lopez-Arrieta, J. M., a me Qizilbash, N. Thiamine no ka maʻi o Alzheimer. ʻO Cochrane Database.Syst.Rev 2000;: CD001498. Nānā kiʻi ʻole.
239. ʻO Avenell, A. a me Handoll, H. H. Nutritional supplementation no ka haki haki ma hope o ka mālama ʻana i ka ʻelemakule. ʻO Cochrane Database Syst Rev 2000;: CD001880. Nānā kiʻi ʻole.

240. Naito, E., Ito, M., Yokota, I., Saijo, T., Chen, S., Maehara, M., a me Kuroda, Y. ʻO ka lawelawe pū ʻana o ka sodium dichloroacetate a me ka thiamine i ke komohana syndrome i hoʻokumu ʻia e ka thiamine-pane. hemahema pyruvate dehydrogenase ʻO J Neurol.Sci 12-1-1999; 171: 56-59.

     Nānā kiʻi ʻole.

241. Matsuda, M. a me Kanamaru, A. [Nā hana olakino o nā maʻi hematopoietic]. Nippon Rinsho 1999; 57: 2349-2355.

     Nānā kiʻi ʻole.
242. Rieck, J., Halkin, H., Almog, S., Seligman, H., Lubetsky, A., Olchovsky, D., a me Ezra, D. Hoʻonui ʻia ka nalo ʻana o ka thiamine e nā haʻahaʻa haʻahaʻa o ka furosemide i nā mea manawaleʻa olakino. ʻO J Lab Clin Med 1999; 134: 238-243. Nānā kiʻi ʻole.
243. ʻO Constant, J. ʻO ka cardiomyopathies ʻalekohola - maoli a pseudo. Cardiology 1999; 91: 92-95. Nānā kiʻi ʻole.
244. ʻO Gaby, A. R. Kūlohelohe i ka epilepsy. Altern. ʻO Rev. Rev. 2007; 12: 9-24. Nānā kiʻi ʻole.
245. Allwood, M. C. a me Kearney, M. C. Hoʻohui a me ke kūpaʻa o nā mea hoʻohui i nā admixtures nutritional parenteral. Nutr 1998; 14: 697-706. Nānā kiʻi ʻole.
246. Mayo-Smith, M. F. ʻO ka mālama ʻana i ka lāʻau lapaʻau o ka haʻalele ʻana i ka wai ʻona. Kahi papa hana meta-analysis a me nā hōʻike hōʻike e pili ana i ka hōʻike. ʻAmelika Hui Pū ʻIa o ka Hoʻohui Kālā Hoʻohālikelike Pūʻulu Hana ma ka Hoʻokele Pharmacological o ka haʻalele ʻana i ka ʻalekohola. JAMA 7-9-1997; 278: 144-151. Nānā kiʻi ʻole.
247. ʻO Sohrabvand, F., Shariat, M., a me Haghollahi, F. Hoʻohui Vitamin B no ka cramp wāwae i ka wā hāpai. Int J Gynaecol.Obstet. 2006; 95: 48-49. Nānā kiʻi ʻole.
248. ʻO Birmingham, C. L. a me Gritzner, S. Hōʻemi puʻuwai i ka anorexia nervosa: hōʻike hihia a me ka loiloi o nā puke. ʻAi. Kaona. 2007; 12: e7-10. Nānā kiʻi ʻole.
249. Gibberd, F. B., Nicholls, A., a me Wright, M. G. Ke ʻano o ka folic acid ma ke alapine o ka hōʻeha epileptic. ʻO Eur J Clin Pharmacol. 1981; 19: 57-60. Nānā kiʻi ʻole.
250. ʻO Bowe, J. C., Cornish, E. J., a me Dawson, M. Ka loiloi ʻana i nā mea kōkua folic acid i nā keiki e lawe ana i ka phenytoin. ʻO Dev. ʻO ke keiki Neurol. 1971; 13: 343-354. Nānā kiʻi ʻole.
251. Grant, R. H. a me nā Hale Kūʻai, ʻo O. P. Folic acid i nā mea maʻi hemahema folate me ka maʻi epilepsy. Br Med J 12-12-1970; 4: 644-648. Nānā kiʻi ʻole.
252. ʻO Jensen, O. N. a me Olesen, O. V. Subnormal serum folate ma muli o ka anticonvulsive therapy. Ke aʻo ʻelua makapō o ka hopena o ka mālama ʻana i ka waikawa folic i nā mea maʻi me nā folat serum folatormal i hoʻokomo ʻia i ka lāʻau. Arch Neurol. 1970; 22: 181-182. Nānā kiʻi ʻole.
253. Christiansen, C., Rodbro, P., a me Lund, M. Ka hopena o ka anticonvulsant osteomalacia a me ka hopena o ka wikamina D: ka lāʻau hoʻōla therapeutic hoʻokolokolo. Br Med J 12-22-1973; 4: 695-701. Nānā kiʻi ʻole.
254. Mattson, R. H., Gallagher, B. B., Reynolds, E. H., a me Glass, D. Folate therapy ma epilepsy. ʻO kahi aʻo i kāohi ʻia. Arch Neurol. 1973; 29: 78-81. Nānā kiʻi ʻole.
255. Ralston, A. J., Snaith, R. P., a me Hinley, J. B. Nā hopena o ka waikawa folic i ke alapine-pinepine a me ka lawena i nā epileptics ma nā anticonvulsants. Lancet 4-25-1970; 1: 867-868. Nānā kiʻi ʻole.
256. ʻO Horwitz, S. J., Klipstein, F. A., a me Lovelace, ʻo R. E. Ka pilina o ka metabolism folate abnormal i ka neuropathy e ulu nei i ka wā lāʻau lapaʻau anticonvulsant. Lancet 3-16-1968; 1: 563-565. Nānā kiʻi ʻole.
257. Backman, N., Holm, A. K., Hanstrom, L., Blomquist, H. K., Heijbel, J., a me Safstrom, G. Hoʻomaʻamaʻa i ka hyperplasia gingival i hoʻokomo ʻia diphenylhydantoin. Scand J Dent Res 1989; 97: 222-232. Nānā kiʻi ʻole.
258. Zhou, K., Zhao, R., Geng, Z., Jiang, L., Cao, Y., Xu, D., Liu, Y., Huang, L., a me Zhou, J. ʻAhui ma waena o ka hui B nā wikamina a me ka thrombosis venous: loiloi ʻōnaehana a me nā meta-analysis o nā haʻawina epidemiological. J.Thromb.Thrombolysis. 2012; 34: 459-467. Nānā kiʻi ʻole.
259. ʻO Poppell, T. D., Keeling, S. D., Collins, J. F., a me Hassell, T. M. Ka hopena o ka waikawa folic i ka hoʻi hou ʻana o ka ulu gingival i hoʻokomo ʻia e phenytoin ma hope o ka gingivectomy. ʻO J Clin Periodontol. 1991; 18: 134-139. Nānā kiʻi ʻole.
260. Ranganathan, L. N. a me Ramaratnam, S. Nā wikamina no ka maʻi epilepsy. Cochrane.Database.Syst.Rev 2005;: CD004304. Nānā kiʻi ʻole.
261. Christiansen, C., Rodbro, P., a me Nielsen, C. T. Iatrogenic osteomalacia i nā keiki epileptic. ʻO ka hoʻokolokolo therapeutic kaohi. ʻO Acta Paediatr. Manaʻo 1975; 64: 219-224. Nānā kiʻi ʻole.
262. Kotani, N., Oyama, T., Sakai, I., Hashimoto, H., Muraoka, M., Ogawa, Y., a me Matsuki, A. ʻO ka hopena analgesic o kahi lāʻau lāʻau no ka mālama ʻana i ka dismenorrhea mua - he pālua -hoʻopaʻa haʻawina makapō. Am.J Chin Med 1997; 25: 205-212. Nānā kiʻi ʻole.
263. ʻO Al Shahib, W. a me Marshall, R. J. Ka hua o ka lā pāma: kona hoʻohana hiki ke hoʻohana ʻia ma ke ʻano he meaʻai maikaʻi loa no ka wā e hiki mai ana? Int.J.Food Sci.Nutr. 2003; 54: 247-259. Nānā kiʻi ʻole.
264. Soukoulis, V., Dihu, JB, Sole, M., Anker, SD, Cleland, J., Fonarow, GC, Metra, M., Pasini, E., Strzelczyk, T., Taegtmeyer, H., a me Gheorghiade, ʻO nā hemahema M. Micronutrient kahi pono kūpono ʻole i ka puʻuwai puʻuwai. ʻO J Am Coll.Cardiol. 10-27-2009; 54: 1660-1673. Nānā kiʻi ʻole.
265. Dunn, S. P., Bleske, B., Dorsch, M., Macaulay, T., Van, Tassell B., a me Vardeny, O. Nutrice a me nā puʻuwai puʻuwai: ka hopena o nā lāʻau lapaʻau a me nā hoʻolālā hoʻokele. Nutr Clin Practice 2009; 24: 60-75. Nānā kiʻi ʻole.
266. Rogovik, A. L., Vohra, S., a me Goldman, R. D. Nā manaʻo palekana a me nā launa pū paha o nā wikamina: pono e noʻonoʻo ʻia nā wikamina i nā lāʻau? Ann. Makahae. 2010; 44: 311-324. Nānā kiʻi ʻole.
267. Roje, S. Wikamina B biosynthesis i nā mea kanu. Phytochemistry 2007; 68: 1904-1921. Nānā kiʻi ʻole.
268. ʻO Vimokesant, S. L., Hilker, D. M., Nakornchai, S., Rungruangsak, K., a me Dhanamitta, S. Nā hopena o ka hua betel a me nā iʻa hū ma ke kūlana thiamin o ka hikina hikina o ka poʻe Thai. ʻO Am J Clin Nutr 1975; 28: 1458-1463. Nānā kiʻi ʻole.
269. ʻO Ives AR, Paskewitz SM. ʻO ka hoʻāʻo ʻana i ka wikamina B ma ke ʻano he home remedies kontra nā makika. ʻO J Am Mosq Control Assoc 2005; 21: 213-7. Nānā kiʻi ʻole.
270. Rabbani N, Alam SS, Riaz S, et al. ʻO ka thiamine therapy kiʻekiʻe loa no nā mea maʻi me ka maʻi diabetes type 2 a me microalbuminuria: kahi noiʻi pilote i kāohi ʻia me kahi makapō makapō. Diabetologia 2009; 52: 208-12. Nānā kiʻi ʻole.
271. Jacques PF, Taylor A, Moeller S, et al. ʻO ka lawe ʻana o ka nutrient no ka wā lōʻihi a me ka hoʻololi o 5 mau makahiki i nā opacities nukelea. Arch Ophthalmol 2005; 123: 517-26. Nānā kiʻi ʻole.
272. Babaei-Jadidi R, Karachalias N, Ahmed N, et al. Kāohi ʻana i ka nephropathy diabetic incipient e ka thiamine kiʻekiʻe a me ka benfotiamine. Diabetes. 2003; 52: 2110-20. Nānā kiʻi ʻole.
273. Alston TA. Hoʻopilikia paha ka metformin me ka thiamine? - Pane. Arch Intern Med 2003; 163: 983. Nānā kiʻi ʻole.
274. Koike H, Iijima M, Sugiura M, et al. ʻO ka neuropathy ʻalekiko he klinikopathologically ʻokoʻa mai ka neuropathy thiamine-def defence. Ann Neurol 2003; 54: 19-29. Nānā kiʻi ʻole.
275. Wilkinson TJ, Hanger HC, Elmslie J, et al. ʻO ka pane i ka mālama ʻana i ka hemahema thiamine subclinical i ka ʻelemakule. 'Am J Clin Nutr 1997; 66: 925-8. Nānā kiʻi ʻole.
276. ʻO ka lā E, Bentham P, Callaghan R, et al. ʻO Thiamine no Wernicke-Korsakoff Syndrome i ka poʻe i makaʻu i ka hana ʻino ʻana. ʻO Cochrane Database Syst Rev 2004;: CD004033. Nānā kiʻi ʻole.
277. Hernandez BY, McDuffie K, Wilkens LR, et al. ʻO nā papaʻai a me nā leʻaleʻa premalignant o ka cervix: hōʻike o kahi kuleana pale no folate, riboflavin, thiamin, a me ka wikamina B12. Ka hopena o ka maʻi ʻaʻai maʻi 2003; 14: 859-70. Nānā kiʻi ʻole.
278. Berger MM, Shenkin A, Revelly JP, et al. ʻO ke kaulike keleawe, selenium, zinc, a me thiamine i ka wā o hemodiafiltration venovenous venovenous i nā mea maʻi maʻi nui. ʻO Am J Clin Nutr 2004; 80: 410-6. Nānā kiʻi ʻole.
279. Hamon NW, Awang DVC. Hale Lio. Hiki iā Pharm J 1992: 399-401.
280. Vir SC, Aloha AH. Ka hopena o nā ʻohana contraceptive oral ma ke kūlana thiamin. Int J Vit Nutr Res 1979; 49: 291-5.
281. ʻO Briggs MH, ʻo Briggs M. Thiamine kūlana a me nā mea hoʻopōkole waha. Contraceptive 1975; 11: 151-4. Nānā kiʻi ʻole.
282. De Reuck JL, Sieben GJ, Sieben-Praet MR, et al. ʻO ka encephalopathy a Wernicke i nā mea maʻi me nā tumors o nā ʻōnaehana lymphoid-hemopoietic. Arch Neurol 1980; 37: 338-41 .. Nānā i ka abstract.
283. Ulusakarya A, Vantelon JM, Munck JN, et al. ʻO ka hemahema Thiamine i kahi mea maʻi e loaʻa ana i ka chemotherapy no ka leukemia myeloblastic nui (leka). Am J Hematol 1999; 61: 155-6. Nānā kiʻi ʻole.
284. Aksoy M, Basu TK, Brient J, Dickerson JW. ʻO ke kūlana Thiamin o nā mea maʻi i mālama ʻia me nā hui lāʻau i loaʻa me 5-fluorouracil. ʻO Eur J Cancer 1980; 16: 1041-5. Nānā kiʻi ʻole.
285. ʻO Thorp VJ. Ka hopena o nā ʻohana contraceptive waha ma nā huamona a me nā koi mineral. J Am Diet Assoc 1980; 76: 581-4 .. Nānā i ka abstract.
286. ʻO Somogyi JC, Nageli U. Antithiamine hopena o ke kofe. Int J Vit Nutr Res 1976; 46: 149-53.
287. Waldenlind L. Haʻawina e pili ana i ka thiamine a me ka lawe neuromuscular. Acta Physiol Scand Suppl 1978; 459: 1-35. Nānā kiʻi ʻole.
288. Hilker DM, Somogyi JC. Nā Antithiamins o nā kumu kumu: ko lākou ʻano kemika a me ke ʻano o ka hana. Ann N Y Acad Sci 1982; 378: 137-44. Nānā kiʻi ʻole.
289. Smidt LJ, Cremin FM, Grivetti LE, Clifford AJ. Ka hopena o ke kūlana folate a me ka lawe polyphenol i ke kūlana thiamin i nā wahine Irish. Am J Clin Nutr 1990; 52: 1077-92 .. Nānā i ka abstract.
290. Vimokesant S, Kunjara S, Rungruangsak K, et al. Hoʻokumu ʻia ʻo Beriberi e nā mea antithiamin i ka meaʻai a me kāna kaohi. Ann N Y Acad Sci 1982; 378: 123-36. Nānā kiʻi ʻole.
291. Vimokesant S, Nakornchai S, Rungruangsak K, et al. ʻO nā ʻano meaʻai e hōʻemi ai i ka hemahema thiamine i loko o nā kānaka. ʻO J Nutr Sci Vitaminol 1976; 22: 1-2. Nānā kiʻi ʻole.
292. Lewis CM, Mōʻī JC. Ka hopena o nā ʻohana contraceptive waha ma thiamin, riboflavin, a me ke kūlana acid pantothenic i nā wahine ʻōpio.Am J Clin Nutr 1980; 33: 832-8 .. Nānā i ka abstract.
293. Patrini C, Perucca E, Reggiani C, Rindi G. Nā hopena o ka phenytoin i ka in vivo kinetics o thiamine a me nā phosphoesters i nā ʻiʻo pūʻiwa iole. ʻO Brain Res 1993; 628: 179-86 .. Nānā i ka abstract.
294. ʻO Botez MI, Joyal C, Maag U, Bachevalier J. Cerebrospinal wai a me nā kikoʻī thiamine o ke koko i nā epileptics i mālama ʻia e phenytoin. Hiki iā J Neurol Sci 1982; 9: 37-9 .. Nānā i ka abstract.
295. ʻO Botez MI, Botez T, Ross-Chouinard A, Lalonde R. Thiamine a me ka hoʻomaʻamaʻa folate o nā maʻi epileptic maʻi mau: kahi hoʻopaʻa ʻia me kahi ana Wechsler IQ. Epilepsy Res 1993; 16: 157-63 .. Nānā i ka abstract.
296. Lubetsky A, Winaver J, Seligmann H, et al. ʻO ka exiecie thiamine urinary i kaʻiole: nā hopena o ka furosemide, nā diuretics ʻē aʻe, a me ka ukana o ka leo. J Lab Clin Med 1999; 134: 232-7 .. Nānā i ka abstract.
297. Saif MW. Aia kekahi kuleana no ka thiamine i ka hoʻokele ʻana i ka maikaʻi ʻole o ka puʻuwai congestive? (leka) Hema Med J 2003; 96: 114-5. Nānā kiʻi ʻole.
298. Leslie D, Gheorghiade M. Aia kekahi kuleana no ka thiamine supplementation i ka hoʻokele o ka puʻuwai maikaʻi ʻole? ʻO Am Heart J 1996; 131: 1248-50. Nānā kiʻi ʻole.
299. Levy WC, Soine LA, Huth MM, Fishbein DP. Thiamine hemahema i loko o ka congestive puʻuwai ʻole (leka). 'Am J Med 1992; 93: 705-6. Nānā kiʻi ʻole.
300. Alston TA. Hoʻopilikia ka metformin me ka thiamine? (leka) Arch Int Med 2003; 163: 983. Nānā kiʻi ʻole.
301. Tanphaichitr V. Thiamin. I: Shils ME, Olson JA, Shike M, Ross AC, Eds. Nūhou hou i ke olakino a me nā maʻi. 9th ed. ʻO Baltimore, MD: Williams & Wilkins, 1999. pg.381-9.
302. ʻO Goldin BR, Lichtenstein AH, Gorbach SL. Nā hana kūpono a me nā metabolic flora o ka ʻōpū. I: Shils ME, Olson JA, Shike M, eds. Nūhou hou i ke olakino a me nā maʻi, 8th ed. Malvern, PA: Lea & Febiger, 1994.
303. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Hoʻohui me omega-3 polyunsaturated fatty acid i ka mālama ʻana i ka dismenorrhea i nā ʻōpio. ʻO Am J Obstet Gynecol 1996; 174: 1335-8. Nānā kiʻi ʻole.
304. ʻO Cumming RG, Mitchell P, Smith W. Diet a me ka cataract: ʻo ka Blue Mountain Mountains Study Study. Ophthalmology 2000; 10: 450-6. Nānā kiʻi ʻole.
305. Kuroki F, Iida M, Tominaga M, et al. ʻO ke kūlana huaola he nui i ka maʻi o Crohn. Hoʻohui me ka hana maʻi. Dig Dis Sci 1993; 38: 1614-8. Nānā kiʻi ʻole.
306. Ogunmekan AO, Hwang PA. A randomized, pālua makapō, placebo-kāohi, hoʻokolohua hoʻokolohua o D-alpha-tocopheryl acetate (wikamina E), ma ke ʻano he add-on therapy, no ka maʻi epilepsy i nā keiki. Epilepsia 1989; 30: 84-9. Nānā kiʻi ʻole.
307. Gallimberti L, Canton G, Gentile N, et al. ʻO ka waikawa gamma-hydroxybutyric no ka mālama ʻana i ka syndrome withdrawal alkohol Lancet 1989; 2: 787-9. Nānā kiʻi ʻole.
308. ʻO Yates AA, Schlicker SA, Suitor CW. Nā ʻai kuhikuhi papaʻai: Ke kumu hou no nā ʻōlelo paipai no ka puna a me nā mea pili e pili ana, nā wikamina B, a me choline. ʻO J Am Diet Assoc 1998; 98: 699-706. Nānā kiʻi ʻole.
309. ʻO Beers MH, Berkow R. Ka Merck Manual o Diagnosis a me Therapy. 17th ed. West Point, PA: Merck and Co., Inc., 1999.
310. Drew HJ, Vogel RI, Molofsky W, et al. Ka hopena o ka folate ma phenytoin hyperplasia. ʻO J Clin Periodontol 1987; 14: 350-6. Nānā kiʻi ʻole.
311. Brown RS, Di Stanislao PT, Beaver WT, et al. ʻO ka lawelawe ʻana o folic acid i nā mākua epileptic i hoʻokumu ʻia me ka hyperplasia gingival i hoʻokomo ʻia e phenytoin. ʻO kahi makapō makapō, makapō, placebo-kāohi, like aʻo. Kaha ʻallelo ʻ Medlelo Laha Med Laha Papu 1991; 70: 565-8. Nānā kiʻi ʻole.
312. Seligmann H, Halkin H, Rauchfleisch S, et al. ʻO ka hemahema o Thiamine i nā mea maʻi me ka puʻuwai puʻuwai ʻole i loaʻa i kahi manawa lōʻihi ʻo furosemide therapy: kahi aʻo pailaka 'Am J Med 1991; 91: 151-5. Nānā kiʻi ʻole.
313. Pfitzenmeyer P, Guilland JC, dʻAthis P, et al. ʻO ke kūlana Thiamine o nā maʻi ʻelemakule me ka maikaʻi ʻole o ka puʻuwai me nā hopena o ka supplementattion. Int J Vitam Nutr Res 1994; 64: 113-8. Nānā kiʻi ʻole.
314. ʻO Shimon I, Almog S, Vered Z, et al. Hoʻonui i ka hana ventricular hema ma hope o ka thiamine supplementation i nā mea maʻi me ka puʻuwai puʻuwai ʻole i loaʻa i kahi lōʻihi furosemide therapy. 'Am J Med 1995; 98: 485-90. Nānā kiʻi ʻole.
315. Brady JA, Pōhaku CL, Horneffer MR. ʻO ke kūlana Thiamin, nā lāʻau diuretic, a me ka hoʻokele ʻana i ka maikaʻi ʻole o ka puʻuwai congestive. ʻO J Am Diet Assoc 1995; 95: 541-4. Nānā kiʻi ʻole.
316. ʻO McEvoy GK, hoʻoponopono. ʻO ka ʻike ʻo AHFS Ka lāʻau. Bethesda, MD: ʻAmelika Hui Pū ʻIa o Health-System Pharmacists, 1998.

Nānā hope - 08/19/2020